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ABSTRACT

INTRACELLULAR DELIVERY OF NANOMATERIALS FOR SUB-CELLULAR
IMAGING AND TRACKING OF BIOMOLECULES
Krishna Kiran Medepalli
November 26,2012

Nanomaterials have many intriguing applications in biology and medicine.
Unique properties such as enhanced electrical properties, increased chemical reactivity
and resistance to degradation, novel optical properties and comparable size to that of
biological systems have led to their use in various biomedical applications. The most
important applications of nanomaterials for medicine are in drug delivery and imaging.
This research focuses on utilizing the biocompatibility of single walled Carbon nanotubes
(SWCNTs) and optical properties colloidal quantum dots (QDs) for cellular drug delivery
and imaging of biomolecules.
The first part of this research deals with single walled carbon nanotubes
which are excellent candidates for targeted drug delivery applications due their unique
structural and functional properties. However, prior to their use in therapeutics, their
biocompatibility needs to be thoroughly investigated. The objectives ofthis research were
to establish the biocompatibility of SWCNTs and demonstrate their use as drug delivery
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carriers into cells. Blood, a living tissue, is chosen as the biological system as it contains
various cells which can potentially interact with SWCNTs during the delivery
mechanism. The interactions of these cells in the blood (specifically white blood cells or
leukocytes) with the SWCNTs provide vital information regarding the immune response
of the host to the nanotubes. This research investigates the immune response of white
blood cells due to SWCNTs via (a) direct interaction - presence of nanotubes in the
blood and, (b) indirect interaction - presentation of nanotubes by antigen-presenting-cells
to white blood cells. These two interactions recreate the innate and adaptive immune
responses occurring in the body to any foreign substance. SWCNTs are functionalized
with single stranded DNA (ss-DNA), which serves as a dispersant ofnanotubes as well as
a backbone for further attachment of other biomolecules of interest. Confocal microscopy
and flow cytometric studies are performed to characterize the interactions. Results from
this acute immune response study demonstrate the biocompatibility of SWCNTs in whole
blood and also confinn the cellular delivery of single stranded DNA.
The second part of the research is on colloidal quantum dots (QDs):
nanometer sized semiconductor crystals typically between 1 run to 20 nm in diameter. In
addition to being size comparable with many biological systems, and having large surface
area for multiple biomolecules attachment, they possess high resistance to chemical and
photo degradation, tunable emission based on size and composition which makes them
excellent candidates for cellular delivery and imaging. The main objectives of this
research was to demonstrate the use of QDs for cellular imaging as well as targeted
biomolecule delivery by conjugating the QDs with an antibody to a functional protein
and delivery into live cells. Conventional techniques deliver QDs as aggregates, however,
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a major challenge in the use of QDs for cellular imaging and biomolecule delivery is
acheiving freely dispersed QDs inside the cells. In this research, a new technique to
deliver monodispersed QDs inside live cells was developed. The approach combines
osmosis driven fluid transport into cells achieved by creating hypotonic environment and
reversible permeabilization using low concentrations of cell permeabilization agents like
Saponin. The results confirm that highly efficient endocytosis-free intracellular delivery
of QDs can be accomplished using this method. Confocal microscopy is used to image
the QDs inside the cells and flow cytometry is used for quantifying the fluorescence. To
demonstrate targeted delivery, QDs are

co~ugated

to the antibody of a protein: the

nuclear transcriptional factor, NFkB (Nuclear Factor kappa-light chain-enhancer of
activated B cells) using EDC/sulfo NHS chemistry methods. NFkB is a family of proteins
with 5 different subunits and is involved in a variety of biological processes such as
immune and inflammatory responses and cellular developmental processes. In
unstimulated cells, NFkB is inactive in cytoplasm and translocates to the nucleus upon
stimulation using bacterial products, viruses, radiation, and the like. QDs fluorescence
could be used to monitor NFKB activity over extended periods of time in live cells.
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CHAPTER I - INTRODUCTION

"The principles of physics, as far as I can
see, do not speak against the possibility of
maneuvering things atom by atom."
Richard Feynman, 1959. 1
1.1 INTRODUCTION

Nanotechnology provides the ability to build molecular systems which can be
manipulated atom by atom through the control over the structure of matter at the
molecular level. Nobel Laureate Richard Feynman is credited for foreseeing the concept
of nanotechnology in his talk "There is plenty o/room at the bottom" in 1959. 1
Nanomaterials are at the cutting edge of this rapidly developing technology.
Traditionally, two complimentary approaches to nanomaterials are studied - the topdown approach, where the bulk material is machined down to the nanoscale and the
bottom-up approach, building the material starting at the molecular or atomic level. Both
these approaches are very widely used to create structures on the nanometer scale with
the ability to manipulate at atom-by-atom precision. The fundamental properties of
materials at the nanoscale are significantly different from the bulk. This is mainly due to
the

large

fraction

of

surface

atoms,

1

high

surface

energy,

spatial

confinement and reduced defects. The properties of the nanomaterials like the size
dependent physical and chemical properties, novel electronic and optical properties have
been thoroughly studied. Now, the nanomaterials have entered into an application and
commercialization exploration stage. 2 , 3 In addition to the plethora of applications such as
in electronics, optics and materials science, nanomaterials are very widely used in many
biomedical applications. 4•7 The relevant processes in many biological systems occur at
the nanometer scale regime. Moreover, many of the elementary biological units such as
DNA, proteins and cell membranes are in this nanoscale dimension. Therefore,
nanomaterials are widely used in the biomedical field to better comprehend how the
subcellular molecules, cells, tissues and organs function at fundamental level. This
integration of the concepts of nanotechnology in biology and medicine is generally
referred to as the field of nanomedicine. 8
Nanomedicine broadly is defined as the technology that deals with the use of
nanostructured materials as molecular tools for medical diagnosis and treatment. In recent
years significant efforts are made toward understanding the molecular basis of diseases. 9
As a consequence, new therapies have been developed to focus on targeting signalling at
the cellular level. 10 A major advancement in this area is the use of gene therapy to
introduce, remove or silence genes within a cell. II Delivery of genes or small interference
RNA (siRNA) for gene silencing to the nucleus of the cells for gene therapy is
challenging. Traditionally, the methods for delivery have been viral vector based
approaches. Despite advantages like high transfection efficiency, high tropism and
natural delivery method, viral methods have several disadvantages. The process itself is
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complicated and can result in chromosomal insertion, oncogene activation, strong
immune reactions and contamination with live virus.
Novel nanomaterials like carbon nanotubes, colloidal crystals, magnetic
nanoparticles and quantum dots are being studied for drug delivery applications. 12 - 15 The
selective delivery

of drugs

using targeted

nanomaterials

avoids

unnecessary

complications and increases the effectiveness of the drug delivered. Another major area
for application of nanomaterials is cellular labelling and bio imaging. Semiconducting
nanomaterials like single wall carbon nanotubes, nanoparticles and quantum dots possess
superior optical properties than conventional labels. More recently, nanomaterials have
been used to stimulate, and interact with target cells and tissues in controlled ways to
induce desired physiological responses. 16
1.2 PURPOSE OF THE STUDY

The purpose of this dissertation study is to demonstrate the intracellular delivery
of nanomaterials for subcellular imaging and tracking of biomolecules. Specifically, two
novel nanomaterials - single wall carbon nanotubes (SWCNTs) and colloidal quantum
dots (QDs) are described.
Single walled carbon nanotubes (SWCNTs) have been widely used for many
biomedical applications such as gene and biomolecular delivery applications. Though
several in vitro and in vivo models are studied to evaluate the biocompatibility of the
SWCNTs, their interactions with blood (specifically blood leukocytes) is not extensively
investigated. In this dissertation, two possible interactions (direct and indirect) of
SWCNTs with blood leukocytes are recreated in vitro and the response of the leukocytes
3

to SWCNTs is thoroughly investigated. Despite the limitation of not being able to
observe long term effects, this study provides a good starting point in trying to evaluate
the activation of the blood leukocytes in response to SWCNTs.
Semiconducting nanoparticles or quantum dots (QDs) offer several advantages
over traditional fluorescent molecules (organic dyes) such as high resistance to
photobleaching and size tunable fluorescence emission making them excellent candidates
for imaging and biomolecular delivery applications. However, a major challenge is to
achieve freely dispersed QDs in live cells. Traditional methods such as endocytosis,
lipids based delivery, electroporation are used which accomplish delivery of QDs into
live cells as aggregates and trapped in vesicles. This limits the utility of the QDs for
further labelling of other intracellular components or their specific targets. In this
dissertation, efficient intracellular delivery of QDs in live cells is demonstrated using a
novel reversible permeabilization technique. This approach combines the use of osmosis
driven fluid transport into cells which is achieved by creating hypotonic environment and
reversible permeabilization using low concentration of cell permeabilization agents like
Saponin.
In this dissertation, Chapters II-IV deal with Carbon nanotubes while the chapters
V-VII deal with quantum dots. Chapter II discusses the fundamental properties and the
functionalization of SWCNTs for their use in biomedical applications. Chapter III
discusses the novel approach developed in this dissertation to evaluate the interactions of
SWCNTs with the (direct and indirect interactions) blood. The materials and methods
used in this study are presented including the preparation of SWCNTs dispersions and
isolation of peripheral mononuclear cells from the blood. Chapter IV presents the results
4

obtained from direct and indirect interaction experiments of SWCNTs to blood
leukocytes. Chapter V discusses colloidal quantum dots and the techniques used to
conjugate QDs with various biomolecules. Chapter VI discusses the motivation behind
the use of QDs in this dissertation. A novel technique developed in this dissertation based
on the reversible permeabilization of live cells for the efficient delivery of QDs is
described. Additionally, the potential of QDs: antibody (NF-kB p65) conjugates to label
subcellular protein (NF-kB) is also discussed. Chapter VII presents the results obtained
from the intracellular delivery of QDs using the reversible permeabilization technique.
The activation, nuclear translocation and labelling of NF-kB protein using QDs: NF-kB
p65 antibody conjugates is demonstrated. Chapter VIII provides the conclusions and
potential future directions for research based on the results presented in this dissertation.
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CHAPTER II -CARBON NANOTUBES

2.1 INTRODUCTION
Carbon nanotubes (CNTs) are one dimensional nanomaterial made of carbon with
a cylindrical nanostructure and with diameters of a few nanometers. Carbon nanotubes
were first synthesized in 1991 at the NEC laboratories, Japan using an arc discharge
evaporation method typically used for fullerene synthesis. 17 Their unique properties have
led to their use in various applications in nanotechnology I8-2o, electronics21 -23 , optics24,25
and materials science. 26-28 More recently, they have been widely used in many
applications in the biomedical field like delivery oftherapeutics,29-31 cancer diagnostics/'
32, 33 and tissue engineering. 34, 35
This chapter briefly discusses the intriguing functional properties of the carbon
nanotubes. The bio-functionalization of the CNTs and their biomedical applications are
presented. An overview on the toxicity studies of1he CNTs is also discussed. Finally, the
use of CNTs in this dissertation research is given.

2.1.1 Synthesis and properties
CNTs are single or multiple cylindrical sheets of graphene. Therefore, they not
only possess the inherent properties of their source graphite but also possess unique
structural, electrical, mechanical, optical and biological properties. Primarily, they are
classified based on the number of graphene sheets they are made of. When a single
graphene sheet forms a nanotube, they are referred to as single walled carbon nanotubes
6

(SWCNTs) whereas multiple sheets of graphene or multiple SWCNTs nested together
coaxially are referred to as multi-walled carbon nanotubes (MWCNTs).36 A high
resolution transmission electron microscope images of coaxial tubes of graphitic sheets is
shown in Figure 2.1

Figure 2.1 High resolution TEM images of MWCNTs formed by (a) five, (b) two, (c)
seven graphene sheets. 17

Synthesis of CNTs

Typically, CNTs are grown USlllg three mam methods- arc discharge, laser
ablation and chemical vapor deposition (CVD) (which uses transition metal catalyst
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particles (Co, Fe, Ni) for the growth).37 In 1993, two seminal reports independently
described SWCNTs synthesis using arc the discharge method in the presence of a metal
catalyst. 38,39 The arc discharge method involves heating a doped graphite rod with an
electric arc, and results in low purity due the amorphous carbon and low yield. Large
quantities of MWCNTs

(~

in gram quantities) with diameters ranging from few

nanometers to tens of micrometers have been synthesized using a variant of the arc
discharge method. 4o In 1996, the synthesis of CNTs with high yield and purity was
accomplished using a laser vaporization method developed by Nobel laureate Richard
Smalley41 In the laser ablation method, a graphite target is vaporized using laser pulses in
the presence of the catalyst particles. The nanotubes synthesized using the laser ablation
method are of higher purity than those synthesize using the arc discharge method. CVD
method for the synthesis of CNTs involves the decomposition of a carbon precursor gas
over catalytic metal particles typically lying on a substrate. CVD growth of nanotubes is
commonly used to produce highly pure CNTs with high yield. The most common
precursor gases are used in the CVD synthesis of CNTs are methane, acetylene and
ethylene.
Properties of CNTs
The fundamental physical, mechanical and electronic properties of CNTs are well
reported and understood. This section gives a brief overview of the fundamental
properties of CNTs with emphasis on the functional properties which are exploited for
the use of CNTs in biomedical field. The excellent mechanical properties of the CNTs are
due to the Sp2 hybridized C-C bonds. This results in very high Young's modulus
(~1000GPa)

and tensile strength of about 50 times stronger than steel. The quantum
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confinement of the conduction band electrons, their nanoscale diameter with long lengths
makes them excellent one-dimensional conductors. The electronic properties of the CNTs
arise from the manner in which the underlying graphene sheet is rolled. A pair of indices
(n, m) is used to denote the number of unit vectors along the two directions in the
honeycomb lattice structure of the graphene sheet. Typically, the CNTs are specified in
terms of diameter (d) and the chiral angle (9), and the chiral vector (Ch). The chiral vector
is defined in terms of the crystal lattice indices (n, m) and the basic vectors a) and a2 as
Ch=na)+ma2 (Figure 2.2).42-45

Figure 2.2 Diagram showing the 2D graphene sheet and the vector structure classification
to define CNTs structure using the chiral indices (n, m). 42 Open circles represent
semiconducting and solid circles represent metallic CNTs respectively.
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The values of the indices (n, m) detennine the chirality of the CNTs and a change in these
parameters affects their electrical, optical and mechanical properties. Two types of CNTs
exist depending on their electronic band structure. If the value of n=m, then the resultant
nanotube is referred to as armchair nanotube. When m=O, it is called as a zigzag
nanotube. Both the armchair and zigzag are collectively tenned as achiral nanotubes. Any
other values for the indices (n, m) fonn a chiral nanotube. The diameter of the nanotube
is defmed by the fonnula:

where a is the length of the unit vector which is approximately 2.46 AO. 46
Figure 2.2 shows the chiral indices (n, m) of a range of nanotubes, with the open circles
representing the semiconducting nanotubes and the solid circles representing metallic
nanotubes. It is observed that armchair nanotubes are all metallic while one-third of
zigzag and chiral nanotubes are metallic, and the rest are semiconducting.45 It is
theoretically calculated that when n= m (armchair tubes), the energy bands cross the
Fenni level, giving rise to their metallic nature. 43 Also it is predicted that when n - m = 3
xL (L is an integer), then the CNTs are metallic in nature, and when n - m f. 3 x L, then
the tubes fonned are semiconducting in nature with an energy gap in the order of
approximately O.SeV. These theoretical predictions are confinned by experiments that
measure the density of states (DOS) of the CNTs (Figure 2.3). The DOS of the CNTs
have a number of sharp peaks or van-Hove singularities each of which corresponds to a
quantum sub band. The energy gaps of the semiconducting CNTs is inversely
proportional to the diameter of the tubes and at fairly large diameters, the energy gap
approaches to zero, i.e., to that of the graphene sheet itself. As shown in the Figure 2.3, it
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can be seen that the first energy gap is wider for metallic tubes than that of
semiconducting tubes. As the energy is increased, van-Hove singularities appear at
specific energy levels.
2.2 CNTs IN THE BIOMEDICAL FIELD
2.2.1 Bio-functionalization
The most attractive property of the CNTs which is widely exploited in the
biomedical field is their ability to be functionalized with various biomolecules resulting
in their integration in a variety of applications. The following section discusses the
various methods used to functionalize CNTs for biological applications.

a)
m tal

-60

0.0

t.o

Energy (eV)

Zigzag OIOotube (7,0)

Figure 2.3 Density of states of (a) armchair CNT (5,5) exhibiting metallic character and
(b) zigzag CNT (7,0) with semiconducting in nature. 47
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The high surface area, varied electronic properties, and excellent chemical and
thermal stability has led to CNTs being used for many biological applications. 48, 49 The
major difficulty in the use of CNTs in bio-applications is their poor solubility and
polydispersity in aqueous and non-aqueous solvents. Chemical modification of CNTs has
been studied extensively to efficiently functionalize them with various functional
moieties. 50-53 A number of methods have been developed for bio-functionalization of
CNTs with proteins, nucleic acids and various other biomolecules. 54 Some of the most
commonly used methods are discussed here.

~
(c)

~ ==-i~=

Figure 2.4 Bio-functionalization of CNTs using (a) covalent functionalization, (b) noncovalent interactions, (c, d) hybrid approach.54
The methods ofCNTs bio-functionalization are classified (depending on the nature ofthe
interactions of biomolecule to the CNTs) into covalent functionalization, non-covalent
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functionalization and hybrid approaches (Figure 2.4). The most common method for
covalent functionalization of CNTs involves two steps. In the first step, the CNTs are
oxidized using strong acids such as HN03 and H2S04 which results in the formation of
carboxyl groups (-COOH) at the open ends and defect sites on the surface. 55 In the next
step, biomolecules containing reactive amine groups are covalently attached to the
carboxyl groups on the CNTs surface. Though the covalent functionalization of CNTs is
one of the simplest approaches, it is the least specific and excessive oxidation may lead to
the damage of the structure of the CNTs (Figure 2.4a).
The large aromatic (n-electrons) hydrophobic surface of CNTs makes them
excellent candidates for non-covalent interactions with suitable biomolecules. The
hydrophobic interactions are strong and can be utilized to attach various biomolecules
(Figure 2.4b). The interactions can also take place inside the CNTs; however, their small
internal diameter (1-2 nm) limits the use of internal functionalization. A hybrid approach
for the bio-functionalization of CNTs involving both the non-covalent and covalent
interactions for CNTs bio-functionalization also exists. In the fIrst step, an 'anchor'
molecule is attached to the CNTs using the non-covalent interaction method. In the
second step, a chemical reaction links the anchor molecule to the biomolecule of interest.
(Figure 2.4c, d). The non-covalent method as well as the hybrid method does not involve
any chemical modification of the surface, thus the intrinsic structural properties of the
CNTs are preserved. However, the non-covalent approach can result in nonspecific
binding of molecules to the CNTs.
In this dissertation, SWCNTs are bio-functionalized with DNA using the non-

covalent approach. The use of non-covalent interactions between DNA and CNTs was
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first reported by Tsang et al and Guo et al. 56, 57 They functionalized CNTs with platinated
and iodinated helical double stranded DNA and used them as probes for visualization of
DNA. Zheng et al. functionalized SWCNTs with single stranded DNA (ss-DNA) using a
simple sonication and centrifugation procedure. 58 Molecular simulations revealed that the
ss-DNA helically wraps the SWCNTs and separates them, thus avoiding aggregation of
the nanotubes. As shown in Figure 2.5,the hydrophobic nucleic acid bases (red) stack on
the surface of the nanotubes while the sugar phosphate backbones of the nucleic acids
point outward from the sidewall into the aqueous environment. The binding of ss-DNA
with the SWCNTs competes quite effectively with that of the tube-tube interactions.

Figure 2.5 Simulation showing the wrapping of DNA on a SWCNT. The nuclei acid
bases are color coded red while the sugar phosphate backbone is depicted in yellow. 58

2.2.2 Biological applications

The bio-functionalization of the CNTs has led to their use in many biological
applications including drug delivery, biological sensing, and medical diagnostics?9, 59
Some of the recent and more popular biological applications are discussed in this section.
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CNTs are of particular interest in gene and drug delivery due to their ability to be
functionalized with various biomolecules and transported along with their cargo across
the cell membrane. 6o, 61 Physical and biomolecular functionalization appear to be critical
determinants of trans membrane transport. 60 One study in particular has demonstrated
that the length ofCNTs

(~200

nm) is an important determinant of preferential uptake in

mammalian cells. 62 Functionalized SWCNTs were used as molecular transporters of short
interfering RNA (siRNA) into human T cells and primary cells and silenced the
expression of HIV-specific cell-surface receptors and co-receptors. 63 Chemically
functionalized MWCNTs were used as substrate for the culturing and controlling the
growth of the neurons. 64 The SWCNTs functionalized with double stranded DNA and
SWNTs were used for glucose sensing applications. 65 Semiconducting SWCNTs show
strong absorption and fluorescence emission in the near infrared region. 66 They are used
as long term optical labels in cells due to their extremely photo stable fluorescence
emission in the biological transparent near infrared wavelengths.67 The optical absorption
of SWCNTs in the biologically transparent window (700 -1000 nm) was utilized for
selective cancer cells destruction68 . Once SWCNTs are internalized into cells or tissues,
they function as small antennas which absorb laser radiation light that is transferred to the
cells in the form of heat energy, thus triggering cell death. In a similar study, Gannon et
al. exploited the near infra-red absorption of SWCNTs functionalized with a
biocompatible polymer for enhanced destruction of cancer cells using non-invasive
radiofrequency field. 69
Despite establishment of the fact that various mammalian cells uptake SWCNTs
readily, the exact mechanism of uptake is still not well understood. Endocytosis is widely
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speculated as the method for internalization for both covalently and non-covalently
modified CNTs70 while phagocytosis is also considered as a potential pathway.71 In
addition to these cellular processes, passive insertion of the nanotubes modified with
hydrophilic terminus into the cell membrane is also demonstrated. 3o Recent reports also
indicate that SWCNTs transport across the cell membrane is not affected in the presence
of endocytosis inhibitors like sodium azide or reduced temperature suggesting the
existence of several different and energy independent pathways.60
2.3 TOXICITY STUDIES
Before the results and findings from cell culture-based CNTs studies can be
translated to in vivo patient models, the overall effect of CNTs at the cellular level and
the consequence of these events at the systemic level must be thoroughly evaluated.
Several studies have looked at the toxicity of CNTs using cellular-level models. Magrez
et al. investigated the toxicity of carbon based nanomaterials and concluded that acid
treatment ofCNTs led to increased toxicity.72 The toxicity of acid treated MWCNTs was
also reported by Bottini and co-workers who concluded that pristine nanotubes are less
toxic than their acid treated counterparts. 73 Monteiro et.al reported that chemically
unmodified MWCNTs localize within the cytoplasmic vacuoles of human epidermal cells
and initiate an irritation response. 74 Pulskamp et al. reported that the toxicity of CNTs
could be a result of the metal traces associated with the growth processes. 75 Though there
are several reports which suggest the potential toxicity of CNTs, there are several other
reports which claim that CNTs are non-toxic. SWCNTs were functionalized with
fluorescence markers(FITC) and peptides and were used to deliver these molecules into
cell without any apparent toxicity.76 Dumortier et al. reported that functionalized and
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highly water soluble CNTs are non-cytotoxic and preserve the functionality of primary
immune cells. 77 Another study performed by Cui et al. investigated the effect of
SWCNTs on human embryo kidney cells (HEK) and reported that high concentrations of
SWCNTs inhibited cell proliferation while lower concentrations has minimal or very
slight influence on the cells. 78 It was observed that CoMoCAT nanotubes were not
inherently cytotoxic to HeLa cells. The interaction of SWCNTs with human epithelial
like cells was investigated by Yehia et al. and it was observed that the SWCNTs
dispersions are inherently non-toxic to cells. 79 Thus the results from the cell culture
studies seem to vary depending on the cell type, experimental conditions as well as the
dosage and functionalization of the CNTs.
Several in vivo studies on the toxicity of CNTs were reported. Lam et al. studied
the potential pulmonary toxicity in mice and observed that high doses induced lung
lesions while low doses do not show any overt clinical effects.80 Muller et al. investigated
the respiratory toxicity of MWCNTs in rats and reported that the nanotubes induced
inflammatory and fibrotic reactions even after 60 daysY Poland et al. compared the
MWCNTs to asbestos, whose fibers were responsible for a worldwide pandemic of lung
diseases. 82 MWCNTs with diameters around 15-150 nm and lengths from 5-501lm were
used to investigate their toxicity in mesothelial lining of mice. Similar to asbestos, a
length dependent pathogenic behavior was seen, with the observation of lesions and
inflammations. The acute and chronic toxicity of functionalized SWCNTs injected into
the bloodstream of mice was investigated by Gambhir et al. 83 Though it was observed
that SWCNTs persisted in the liver and spleen for 4 months, no cytotoxicity was
observed. More recently, Bai et al. reported that repeated administrations of water soluble
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MWCNTs in mice results in reversible testis damage repairable within 90 days without
any loss of fertility.84 Though there are several reports, no consensus still exists on the
toxicity of CNTS. An appropriate model needs to be established to thoroughly evaluate
the effects ofCNTs on the human body.
2.4 CNTs IN THIS DISSERTATION

In this dissertation, blood is chosen as the appropriate tissue culture model. Blood
perfuses throughout the human body and its cellular populations can potentially interact
with SWCNTs functionalized with ss-DNA. In this dissertation, SWCNTs grown using
CoMoCAT method (Cobalt, Molybdenum catalyst) are used. As purchased SWCNTs are
non-covalently functionalized with ss-DNA and dispersed in aqueous solutions for
biocompatibility. The toxicity of the SWCNTs is studied by evaluating their interactions
with blood cells especially leukocytes (white blood cells) and investigating the response
of leukocytes to SWCNTs.
The next chapter discusses the experimental materials and methods used in this
dissertation to evaluate the toxicity of SWCNTs. The method used to disperse the
SWCNTs and the methods employed to study the response of blood to SWCNTs are
discussed in detail.
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CHAPTER III - INTERACTION OF SWCNTs WITH BLOOD LEUCKOCYTES

3.1 INTRODUCTION
Carbon nanotubes can be functionalized with various biomolecules like proteins
and nucleic acids for gene and drug delivery applications. However, the overall effect of
CNTs on the body at the cellular and systemic level is not well understood. Hence,
interaction of the CNTs with cells for potential toxicity and unnecessary inflammation
needs to be carefully evaluated.
Several studies have been performed to study the response of CNTs using cell
culture 74, 85-87 and animal models. 84, 88, 89 However, the results vary depending on the cell
type, functionalization of the CNTs and experimental conditions. Even though animal
models provide some understanding of the response of body to CNTs, the translation of
those observations to human studies is not straightforward. The response of human
immune system to CNTs is significantly more challenging and has not been extensively
investigated. In this dissertation, the interaction of CNTs with the human immune system
was evaluated by investigating the response of immune cells in the blood to CNTs.
Blood is a living tissue that perfuses the entire body and contains cellular
populations that could potentially interact with CNTs. Hence, evaluation of the different
cellular populations (specifically leukocytes) in blood can potentially provide vital
information

regarding

the

inflammatory
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response

to

the

CNTs.

Blood

samples were isolated from healthy donors to study the interactions of the blood
leukocytes with CNTs. This in vitro study mimics critical events in vivo. The initial
sections of this chapter deal with the basics and the cells involved in the immune
response of the body. The materials and methods used in evaluating the interaction of
CNTs to blood leukocytes are discussed at the end of the chapter.
3.2 IMMUNE RESPONSE IN HUMAN BODY

The resistance of the human body to infections is defined as the immunity of the
body. The cells and biomolecules that help in maintaining this resistance constitute the
immune system of the body. The collective reaction of these cells and molecules to
infections and infectious diseases is the immune response of the body. Thus immunology
is the study of the body's defense against infection. The basic functions of the immune
system are:1. Recognition of the disease causing agents like the bacteria, viruses, microbes and
other pathogens as well as toxins, chemicals, drugs and any other foreign
particles.
2. Removal of the infection causing agents by performing Immune effector
functions.
3. Ability to self-regulate without unnecessary immune response and
4. Immunological memory.
The fundamental function of the immune system is to protect the body from any potential
infectious agents by recognizing specific antigens. Antigens are typically receptor
molecules on the surfaces of the cells, viruses, fungi and bacteria but substances like
toxins, chemicals, drugs or any other foreign objects may also act as antigens. Once the
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antigens are recognized, specialized cells and molecules perform effector functions in
order to remove the infectious agents. An important function of the immune system is the
ability to not respond to the host's own antigens (immunological tolerance). This selftolerance is extremely important in applications like tissue grafts or transplantation
experiments. For example, when tissues are transplanted from one individual to another
individual who are not identical twins, the donor cells are treated as foreign and
destroyed by the recipient's immune system. Here, the antigens on the donor cells
generate immune response even in the absence of any infection. However, when a
neonatal mouse is transplanted with cells from a mouse of different strain, it was
observed that some of these cells survived for most of the recipient's life time. In this
case, the immune system is unresponsive to foreign antigens and is known as acquired
immunological tolerance. In a similar way, immune system acquires tolerance to its own
macromolecules which is known as natural immunological tolerance. The breakdown of
this tolerance to self-antigens leads to autoimmune diseases and the mechanism leading
to this breakdown are relatively unknown.
Another major function of the immune system is to remember prior experiences with
antigens. The immune system creates immunological memory following initial exposure
to antigens. 9o This memory leads to quicker and enhanced response to subsequent
encounters with the same antigen. This memory helps the body develop immunity
towards many common infectious diseases and it is how vaccinations confer long lasting
protection against infections. Typically, the organs in the peripheral lymphoid system
contain three types of cells - naIve cells, effector cells and memory cells. During the
initial encounter with an antigen, naIve cells respond by proliferation and differentiation
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into effector cells which carry out the immune response. At the same time, some of the
naIve cells differentiate into long living memory cells. During the subsequent exposures
to the same antigen, the memory cells respond more quickly than the naIve cells in
creating effector cells to fight the antigen. The memory cells can either differentiate into
effector cells or more memory cells. These memory cells can sometimes live for the
lifetime of an individual providing lifelong immunological memory. A process known as
clonal expansion is responsible for the creation of memory cells from the naIve cells

(Figure 3.1).
3.3 CELLS IN THE IMMUNE SYSTEM
This section deals with the various cells involved in the immune responses in the
body (specifically blood leukocytes). The immune system consists of the lymphoid
tissues and organs of the body. Lymphoid tissues are concentrated majorly in the bone
marrow, lymph nodes, spleen, liver, thymus, and as Peyer's patches scattered in the
linings of the gastrointestinal tract. The distribution of lymphatic tissues that make up the
immune system in the human body is illustrated in the Figure 3.2.
The cells of the immune system originate from a pluripotent hematopoietic stem
cell in the bone marrow. They are divided into two major lineages - myeloid progenitor

cell and lymphoid progenitor cells (Figure 3.3).91 The myeloid cells include monocytes,
macrophages, dendritic cells, meagakaryocytes and granulocytes (cells with the presence
of cytoplasmic granules) while the lymphoid cells consists of T cells, B cells and natural
killer (NK) cells respectively. In the event of hematopoiesis, cells in the bone marrow
develop into either mature cells or precursors of cells that migrate out of the bone
marrow. The bone marrow produces lymphocytes (B-cells, immature T -cells, and NK
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cells), granulocytes (including neutrophils, monocytes and dendritic cells), along with red
blood cells (RBCs) and platelets. The immature T cells leave the bone marrow and
migrate to the thymus where they mature and get released into the blood stream.
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Figure 3.1 Schematic representation of immunological memory function of immune
system. 92

The lymphatic system is a part of the circulatory system that consists of lymphatic
vessels carrying a clear fluid called lymph towards the heart. Lymph nodes are an
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important part of the immune system and are found throughout the body that are mainly
composed of T cells, B cells, dendritic cells and macrophages. The spleen consist of T
cells, macrophages, dendritic cells, NK cells and RBCs and is involved in filtering
antigens directly from the blood. The cells of the immune system are mainly divided into
lymphocytes, specialized cells that capture and display the antigens called antigen
presenting cells (APCs) and effector cells that destroy the antigens (Figure 3.4). The
important functional properties of these major cell populations are discussed in the
following sections.
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Figure 3.2 Anatomy of the major human lymphoid organs. The thymus and bone marrow
(yellow) form the primary lymphoid organs. The other organs (blue) form the peripheral
or the secondary lymphoid organs. 92
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Figure 3.3 Cells of the immune system derive from precursors in the bone marrow
(pluripotent hematopoietic stem cell).91

3.3.1 Lymphocytes

Lymphocytes are a type of blood leukocytes and are very large in number in the
human body (~ 2

x

10 12) which makes the immune system comparable to the liver or
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brain in cell mass. Even though they look morphologically similar, the lymphocytes are
highly heterogeneous in lineage, function and phenotype. They are the only specialized
cells with specific receptors which can recognize various antigens. Lymphocytes are
distinguished by the proteins on their surface which are typically identified by panels of
monoclonal antibodies. A standard nomenclature for these cell surface proteins is the
cluster of differentiation (CD). CD is used to delineate the proteins that define a specific

cell type or cell differentiation stage which are recognized by a cluster of antibodies.
Typically, the cellular populations are defined using a

1+1

or a

I_I

symbol to indicate

whether a certain population expresses or lacks a CD molecule. For example, a "CD3+/
CD4-" cell is one that expresses CD3, but not CD4. Lymphocytes can be divided into
large lymphocytes such as natural killer (NK) cells and smalilymphocytes like T cells
and B cells. A brief description of these lymphocytes is presented in the following
section.
Natural killer (NK) cells

NK cells constitute about 10% of the lymphocytes in the blood and peripheral
lymphoid organs. These cells express specific surface molecules which respond to
intracellular antigens by destroying the infected cells. The infected cells are differentiated
from the normal cells by recognizing the changes in the surface molecules such as MHC
(major histocompatibility complex) class I. NK cells respond to a variety of cell-signaling
protein molecules called cytokines resulting in their activation. Once activated, they
release cytotoxic (cell-killing) granules which can create holes in the plasma membrane
of the infected cells, thereby destroying them. Another major function of activated NK
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cells is to synthesize and secrete cytokines that activates other specialized cells like
macrophages to become more effective in killing the phagocytosed antigens.

IPrincipal function(s)

ICell type

Lymphocytes: B lymphocytes; Specific recognition of antigens:
T lymphocytes· natural
B lymphocytes: mediators of humoral
immunity
kilrer cells
T lymphocytes: mediators of cell-mediated
immunity
Natural killer cells: cells of innate immunity

Blood lymphocyte

Antigen-presenting cells:
dendritic cells; macrophages;
follicular dendritic cells

Capture of antigens for display
to lymphocytes:
Dendritic cells: initiation of T cell responses
Macrophages: initiation and effector phase
of cell-mediated immunity
Follicular dendritic cells: display of antigens
to B lymphocytes in humoral immune
responses

Dendnbc cell

Bbo<! monocyte

Effector cells: T lymphocytes; Elimination of antigens:
T lymphocytes: helper T cells and cytotoxic
macrophages; granulocytes
T lymphocytes
Macrophages and monocytes: cells of the
mononuclear-phagocyte system
Granulocytes: neutrophils, eosinophils

Figure 3.4 The fundamental cells of the immune system. The major cells that mediate
immune responses along with their functions are shown. Microscopy images of some
cells are shown in the left panel.
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T lymphocytes (T cells)

T lymphocytes (T cells) develop in the thymus and hence their name is derived
based on the organs in which they develop. Based on their phenotype and functionality,
they are divided into two major subsets- T helper (Th) cells and cytotoxic T (Tc or CTL)
cells. Mature Th cells express the surface protein CD4 and are referred to as CD4+ T cells.
Th cells coordinate and regulate immune responses by mediating the secretion of
lymphokines or stimulate other immune cells. Hence, the Th cells are called helper cells
as they help other specialized lymphocytes (B cells) to produce antibodies and help
phagocytes (cell which can engulf antigens) to destroy ingested microbes. The second
type ofT lymphocytes is cytotoxic T lymphocytes (Tc cells or CTLs). They are called as
cytotoxic T cells because they lyse the cells which contain intracellular microbes.
Cytotoxic T cells are involved in directly killing certain cancer cells, virus-infected cells
and also some parasites. They are also known as protein CDS+ T cells as they express that
particular protein. These cells are also important in down-regulation of immune
responses. Both the Th as well as Tc cells are located throughout the body in the lymph
nodes and the spleen, liver, lungs, the intestinal tract and also in the blood.
B lymphocytes (B cells)

The lymphocytes that develop in the bone marrow are referred to as B
lymphocytes (B cells). B cells are the only cells which can produce antibodies to fight
infection. The specialized proteins that can recognize and bind to specific antigens that
caused their activation are known as antibodies. Following stimulation by foreign
antigens like bacteria, viruses and infected cells, B cells develop into antibody secreting
plasma cells. B cells not only express antibodies that serve as receptors for antigens but
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also help initiating activation of cells. In addition to differentiating into plasma cells,
some B cells develop into immune memory cells.
The different types of lymphocytes are shown in the Figure 3.5. The development
and activation of both T cells and B cells is shown in the Figure 3.6. Both T and B cells
which originate from the pluripotent hemopoietic stem cells give rise to all of the blood
cells, including RBCs, white blood cells, and platelets.92
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Figure 3.5 The different types of lymphocytes. Different classes of lymphocytes
recognize antigens and differentiate into effector cells which help remove the antigens. B
cells secrete antibodies to fight infection. T helper cells recognize antigens on the
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surfaces of APCs and secrete cytokines. Cytotoxic T cells directly kill the infected cells.
NK cells recognize infected cells via receptors and kill the infected cells. 93
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Figure 3.6 Schematic showing the development and activation ofT cells and B cells.92

3.3.2 Antigen presenting cells (APes)

The second major class of immune cells is the antigen presenting cells or APCs.
Pathogens and microbes enter the body through the skin, gastrointestinal tract or the
respiratory tract. The specialized cells present in the epithelium capture the antigens and
transport them to peripheral lymphoid tissues. Here, the captured antigens are displayed
to T cells; hence these specialized cells are referred to as antigen presenting cells (APCs).
T cells can only recognize antigens when they are processed and presented by cells via
MHC class I and II carrier molecules. Dendritic cells and macrophages typically function
as APCs. Dendritic cells are present in the tissues which are in contact with external
environment such as the skin, epithelia, inner lining of nose and lung as well as in the
blood in immature state. Macrophages are white blood cells which are derived from the
monocytes in the bone marrow. Macrophages phagocytose the antigens which escape
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through the epithelium and display the protein antigens to T cells. The APes not only
display the antigens to T cells but also have the ability to trigger the T cell immune
responses. Such APes are referred to as professional antigen presenting cells (APes).
The professional APes respond to the antigens by first internalizing them via
phagocytosis. Then, they produce surface proteins that activate the naive T cells by
providing an additional co-stimulatory signal for T cell proliferation and differentiation.
A special type of dendritic cells called the follicular dendritic cells which exist in the
germinal centers of the lymphoid follicles display the antigens to B cells thereby
stimulating B cell differentiation.
3.3.3 Effector Cells

The third major cells in the immune system are the effector cells whose function
is primarily to eliminate the foreign antigens or microbes. The effector cells are mainly
constituted by lymphocytes and leukocytes like macrophages and granulocytes. The basic
functions of lymphocytes (T cells and B cells) are discussed in the previous section.
In this section, circulating blood leukocytes are discussed. There are mainly two

types of circulating phagocytes- neutrophils and monocytes that are recruited to the sites
of infection. Neutrophils or polymorphonuclear leukocytes (PMNs) are a subset of
granulocytes and are the most abundant leukocytes in the blood with approximately 4000
to 10,000 cells per mm3 .They serve as the first responders to most of the bacterial and
fungal infections. In the event of infections, production of neutrophils from the bone
marrow increases rapidly, sometimes to 20,000 per mm3. Their production is usually
mediated by cytokines which are produced by many cells in response to any infections.
Monocytes are typically low in number (~ 500-1000 per mm3) in the blood. They ingest
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microbes or foreign antigens present in the blood and can differentiate into macrophages
and dendritic cells in the tissues. Macrophages are activated owing to an immune
response and travel to the site of the infection. The recognition of the pathogens or
microbes by the macrophages results in the phagocytosis of the antigens as well as
activation of the phagocytes to kill the ingested microbes.
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Figure 3.7 Stages in the maturation of mononuclear phagocytes. 93 Monocytes are derived
from bone marrow stem cells differentiate into macrophages in tissues. Macrophages may
be activated in the tissues in response to different antigens and may differentiate into
specialized forms in different tissues. A light and an electron microscopy image of the
macrophage is shown in the lower left panel. An electron microscopy image of an
activated macrophage is shown in the lower right panel.
When a macrophage ingests a pathogen, the pathogen is sequestered in the
intracellular food vacuole, which later fuses with a lysosome. A variety of intracellular
enzymes and toxic peroxides ingest the pathogen. Macrophages secrete interferons,
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lysozyme and other useful factors which activate lymphocytes and other immune cells to
respond to the pathogens. Both neutrophils and monocytes migrate to the site of the
infections and bind to the endothelial adhesion molecules. The migration of leukocytes to
the extravascular infection site occurs within a few minutes. This migration process
follows a sequence of events. Briefly, first these cells roll on the endothelium with the
help of adhesion molecules called selectins; then they are adhered firmly using another
set of adhesion molecules called as integrins. Finally chemoattractant cytokines also
known as chemokines are produced that activate and stimulate the migration through the
endothelium to the site of the infection.
Thus the lymphocytes, antigen presenting cells (APes) and the effector cells are
all involved in the immune response in the body.
3.4. TYPES OF IMMUNE RESPONSE
The immune responses of the body are typically divided into two main categoriesinnate immunity and adaptive immunity, which are discussed in the following section.
3.4.1 Innate Immunity
Innate immunity is the native or natural immunity an individual is born with. It is
the initial host's defense to prevent the entry of infectious agents and rapidly eliminate
the ones which enter. It is an antigen nonspecific defensive response of the body to any
infection or antigen. The first line of defense in this type of response is provided by the
skin and the other epithelial barriers. These barriers prevent the entry of any potential
pathogens acting as a physical barrier between the inside of the body and the outside. The
inner surfaces of the epithelial barriers are coated with mucus layers which are made of
mucin and other glycoproteins. These layers protect the body not only from microbes
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from attaching to the epithelium but also from physical or chemical infections. Low
molecular weight peptides called defensins are found in the lung and gastrointestinal
tracts. They possess the ability to fight gram-negative and gram-positive bacteria, fungi,
parasites and viruses. Chemical agents like fatty acids in the sweat and the lysozyme,
phospholipase in tears and saliva help in the prevention of bacterial growth and
destabilization of bacterial membranes. In the event of infectious agents breaching these
physical barriers, specialized cells such as phagocytes, NK cells and various plasma
proteins recognize and react against the infection. As described in the previous section,
phagocytes like macrophages and neutrophils ingest and kill the pathogens. Thus, the
epithelium, cell in the circulation and tissues and other plasma proteins constitute the
components of the innate immunity.
Innate immunity is divided into immediate innate immunity and early induced
innate immunity. Immediate innate immunity typically starts 0-4 hours following
exposure to an infectious agent and is carried out by circulating anti-microbial enzymes
and proteins in the blood and other anatomical barriers. Early induced innate immunity
typically begins anytime between 4- 96 hours after exposure to an infection and involves
the recruitment of phagocytes like neutrophils, monocytes, macrophages and NK cells.
3.4.2 Adaptive immunity
Adaptive immunity also known as acquired immunity is the response of the host to
stimulation by antigens and other pathogens that infect the tissues. The adaptive
immunity is carried out mainly by lymphocytes and the antibodies produced by them.
The lymphocytes express the receptors that are specific to different antigens and so the
adaptive immunity is antigen specific immune response. Adaptive immune response
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takes a long time to develop, sometimes even several days and one develops this
immunity throughout life. There are two types of adaptive immunity - humoral immunity
and cell-mediated immunity. Humoral immunity involves the mediation of antibodies
produced by B cells. The primary function of the antibodies is to prevent the foreign
antigens present in the blood from gaining access to host cells and tissues. However,
antibodies do not provide protection from intracellular antigens or antigens that live and
divide inside infected host cells. Cell-mediated immunity protects the host from such
intracellular antigens and it is mediated by the specialized T cells. A schematic of the
fundamental mechanisms involved in both innate and adaptive responses is shown in
Figure 3.8.
The most important properties of adaptive immune responses are
1. Specificity.

2. Memory
3. Specialization and
4. Nonreactivity to self-antigens.

Unlike innate immunity, adaptive immune responses possess the ability to recognize
and respond to many different antigens. The immune system can potentially distinguish
millions of different antigens in a highly specific manner. This remarkable specificity is
due to the fact that the lymphocytes involved in this immunity consists of many different
clones each of which expresses an antigen receptor that is different from other clones.
This type of response is predicted by clonal selection theory which states that clones of
lymphocytes specific to different antigens are created before even being exposed to these
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antigens. Therefore an antigen activates only those lymphocyte clones that are already
committed to respond to it.

/Microbe

IInnate immunity I

IAdaptive immunity I
B

I~P~:'

9

..--~ Antibodies
Effector T cells

Complement

I
o

Hours

o
NK

cells

7/

Days

~,r-----~,-------rl,
r.r------~
I ----------_TI----------~I--------~

6

12

1

3

5

Time after infection c::::=:111~

Figure 3.8 Schematic of the fundamental mechanisms involved in innate and adaptive
immunity. The kinetics of the innate and adaptive immune response varies depending on
the type of infection. 93

According to this theory, the immune system functions on the principle of readmade response rather than made-lo-order response. As described in the previous sections,

repeated exposure to the same antigen results in larger and more effective immune
responses. The primary immune response to the first exposure to an antigen is usually
mediated by naive lymphocytes while the subsequent exposures to the same antigens are
mediated by memory lymphocytes. This memory response is usually quick, larger and
more efficient in eliminating the antigens than the primary response. Thus the adaptive
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immune response with its immunological memory provides the body the ability to fight
recurrent infections more efficiently. The specialization property of the adaptive immune
response refers to the optimization of the immune response to different antigens.
Adaptive immunity usually improves upon repeated exposure to a given antigen or
infection. Another vital property of the adaptive immunity is the nonreactivity to selfantigens which prevents immune responses against host cells and tissues.
It is important to note that both the innate and adaptive immune responses work

together to protect the host against any foreign infections. Lymphocytes are the major
contributors in adaptive immunity; however they require the activation of innate
immunity to respond to foreign antigens. APCs like dendritic cells and macrophages
display the foreign microbes or antigens to the T cells and initiate an adaptive immune
response (Figure 3.9).
3.5 EVALUATION OF IMMUNE RESPONSE TO CNTs

The previous sections provide a background of the immune response of the body to
foreign antigens. This section deals with the evaluation of immune response of the body
to CNTs. In order to understand the systemic effects of CNTs to the body, blood was
chosen as an appropriate model system. Blood consists of many of the immune cells that
perfuse the entire body; therefore analysis of cells in blood especially blood leukocytes
provides a unique opportunity to understand inflammation at the both the cellular and
systemic levels.
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In this dissertation. acute response of the blood to CNTs is performed by

extracting blood samples and stimulating the samples in vitro. This study attempts to
replicate the acute response of blood leukocytes directly to CNTs analogous to innate
immune response and indirectly via APCs which is analogous to adaptive immune
response. The CNTs used in this study are functionalized with single stranded DNA (ssDNA) fragments composed of Guanine-Thymine (GT) repeat sequences. The ss-DNA
acts as a surfactant to ensure dispersion and prevent aggregation of the CNTs as well as
has the potential to be further modified with other biomolecules. Two possible interaction
events are recreated which mimic the potential interactions of biomolecules via CNTs in
the body. The first event, a direct interaction event recreates the presence of the CNTs in
the blood circulation while the second event, an indirect interaction event recreates the
activation of the different leukocytes in the blood via APCs with internalized CNTs.
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These two events provide an in vitro alternative to evaluate the acute immune response of
blood leukocytes to CNTs.

3.6 MATERIALS AND METHODS
The following sections discuss the materials and methods and the analysis
procedures for assessing the response of different leukocyte populations to CNTs.

3.6.1 Materials
Carbon nanotubes (eNTs) synthesized using CoMoCAT (Cobalt Molybdenum
catalyst) methods are purchased from Southwest nanotechnologies (Norman, OK). The
carbon nanotubes used in this dissertation are single walled carbon nanotubes and hence
are referred to as SWCNTs from this point forward. Single stranded DNA (ss-DNA) with
repeating Guanine-Thymine (GT)3o is purchased from Operon biotechnologies
(Huntsville, AL). The size of the ss-DNA is 30 bases (alternating G -T bases) and
formula weight is around 10,000Da. The ss-DNA is fluorescently labeled with a
fluorescence dye molecule (FAM-Q) at one of its ends which is used to image the ssDNA inside the cells. Phosphate buffered saline (PBS), 1% HAB (Hank's balanced salt
solution without calcium or magnesium also containing 1% bovine serum albumin, 0.1 %
sodium azide, and ImM ethylenediamine tetraacetic acid), Tris-buffered ammonium
chloride buffer for RBCs lysis, RPMI-1640 cell culture media (ATCC 30-2001) and
ficoll-paque solution are purchased from Sigma Aldrich( St. Louis, MO). Trypsin EDTA
(Mediatech, Manassas, VA) is used to detach the cells from the surface for flow
cytometry studies (BD FACS calibur). The blood leukocytes are stimulated for their
activation using phorbol 12-myristate 13-acetate (PMA) purchased from Calbiochem
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(Billerica, MA). All the antibodies used to label and differentiate various blood
leukocytes are obtained from BD biosciences.
3.6.2 Preparation of SWCNTs-DNA dispersions
SWCNTs are mixed with aqueous ss-DNA (GT)30 sequence with FAM-Q
fluorescent tag, solution (approximately 1 mg Iml concentration) in an eppendrof tube.
The mixture is sonicated in a cup horn sonicator (Cole Parmer 750W CPX) for about 6090 min. The sample is then centrifuged at I6,000g for 60 minutes (Eppendorf centrifuge
5415D), and the supernatant containing individually separated SWCNTs in ss-DNA
solution are collected and resuspended in either Ix PBS or cell culture medium. ss-DNA
wrapped SWCNTs were imaged using fluorescence microscopy (Nikon TE Eclipse
2000).
3.6.3 Blood Isolation
Blood

(~

8 ml) is drawn from healthy volunteers by venipuncture in accordance

with protocols approved by the University of Louisville Institutional Regulatory Board
(IRB). The drawn blood samples are then collected in green top vacctuainers and heparin
is used as anticoagulant. The blood samples are maintained on ice until use. All the blood
samples are obtained from Dr.Ashok Raj in the School of Medicine at the University of
Louisville.
3.6.4 Isolation of the PBMCs from whole blood
As previously described, monocytes mature into antigen presenting cells (APCs)
such as dendritic cells or macrophages. CD 83 is successfully used as a selective marker
for the identification of the cells belonging to dendritic cells lineage. 94,

95

The

differentiation of monocytes into CD83+ dendritic celli macrophage phenotype (referred
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to as macrophages from this point forward) is accomplished as described by Zhou et a1. 96
To evaluate the immune response of the blood cells to SWCNTs, the isolation of
monocytes from whole blood needs to be accomplished. Blood cells with round nuclei
such as monocytes and lymphocytes including T cells, B cells and natural killer (NK) are
collectively referred to as peripheral blood mononuclear cells (PBMCs). They are
isolated from human peripheral blood through a process called density gradient

centrifugation which is based on differential migration of the different cell types during
centrifugation due the presence of a density gradient. Ficoll-paque, a hydrophilic
polysaccharide is used in density gradient media. Briefly, blood is carefully layered on
top of the ficoll-paque solution and the sample is centrifuged. Following the
centrifugation, the blood sample is separated into different layers as shown (Figure 3.10).
The bottom layer contains ficoll-aggregated polymorphonuclear cells such as neutrophils
and RBCs. The diffuse layer immediately above the bottom layer consists of mostly
granulocytes and unbound ficoll solution. The PBMCs including the lymphocytes and
monocytes are located the interface between the ficoll-granulocytes layer and the upper
most plasma-platelet layer. The PBMCs are then carefully removed from the interface
and washed with PBS or cell culture medium to remove any residual ficoll solution.
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Figure 3.10 Isolation of PBMCs from whole blood. Schematic showing (a) layering of
blood over ficoll before centrifugation, (b) the different layers after the density gradient
centrifugation process, and (b) Representative photo of actual blood sample with isolated
PBMCs. (Millipore)

The protocol followed in this dissertation for the isolation of PBMCs from blood is given
below1. Prepare two aliquots of2 mL of whole blood diluted 1:1 (v/v) with Ix sterile PBS.

Note: The dilution of the blood minimizes the aggregation ofRBCs and PBMCs.
Generally, the more diluted the blood sample, the better the purity of the PBMCs.
2. Carefully layer the diluted blood sample over ficoll-paque solution in 1: 1 (v/v) in
a two 15ml centrifuge tubes.
Note: The diluted blood sample is gently pipetted on top the ficoll by holding the
tube at an angle to obtain a clean separation of the blood and ficolliayer.
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3. Centrifuge the sample for 20 minutes at 550g at 4°C in a swinging bucket rotor
without brake.
Note: Higher temperatures (37°C) result in the aggregation of RBCs and thus
reduce the yield.
4. Carefully remove the tubes from the centrifuge without disturbing the different
layers.
5. Carefully extract the mononuclear cells layer at the interface to a new 15 ml
centrifuge tube containing 10 ml of Ix sterile PBS.
6. Centrifuge the isolated mononuclear cells in Ix PBS for 5 minutes at 1100 rpm at
25°C.
7. Discard the supernatant and resuspend the pellet containing the mononuclear cells
in RPMI-1640 cell culture medium (ATCC 30-2001).
3.6.5 Isolation of leukocytes from whole blood
The leukocytes are isolated from the blood by lysis of the RBCs using tris buffer
ammonium chloride (NH4CI) lysis buffer. Briefly, 1 ml of blood is mixed well with 15 ml
of 1x lysis buffer and incubated on a rotary shaker for 5 minutes at room temperature
until the solution turns clear. The cells are then centrifuged for 5 minutes at 1000 rpm at
room temperature. The supernatant containing the lysed RBCs are discarded and the
pellet is resuspended in 1% HAB solution for subsequent experiments.
3.6.6 Monocyte/macrophage maturation study
The PBMCs isolated using the previously mentioned protocol are seeded and
allowed to adhere to the surface of the tissue culture flasks. After approximately 8 hours
the non-adherent cells (lymphocytes) are removed by pipetting. The remaining isolated
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monocytes are cultured with or without of SWCNTs. The differentiation of these
monocytes into dendritic/macrophage phenotype cells is evaluated based on the
expreSSIon of monocyte maturation markers (fluorescently labeled antibodies). The
isolated monocytes are evaluated at four different time points- 0, 2 and 4 day time points.
At each time point, the cells are removed from the surface by trypsinization and
resuspended in 200 I.d of Ix PBS. The cells are then split into two tubes containing lOO1l1
of cell solution and mixed with 100 III of 1% HAB solution and labeled with 10 III each of
fluorescently labeled antibodies respectively. After 30 minutes of incubation at 4°C,
stained cells are washed with 500 III of 1% HAB solution added to each of the two tubes.
The cells are then centrifuged for 5 minutes at 1100 rpm and resuspended in 250 III of 1%
HAB solution. The cells are then transferred into two flow cytometer tubes and are
analyzed for the phenotype (maturation) and activation markers using flow cytometry.
Specifically, the expression of CD83 macrophage/dendritic cell marker is used to
evaluate the maturation of the monocytes into macrophages. The internalization of
SWCNTs:ss-DNA within macrophages is confirmed using fluorescently labeled ss-DNA
by confocal microscopy (Nikon Al Confocal System).
3.6.7 Flow cytometry analysis
The evaluation of cellular structure and functions and the interaction of molecules
can be studied by fluorescent based methods like microscopy and flow cytometry. This
section gives a brief description on the basics of flow cytometry. Flow cytometry is
typically used to analyse various parameters of cells in a heterogeneous population and is
widely used in immunophenotyping, cell counting, fluorescence expression analysis and
also cell sorting applications. 97 - lOo This analysis is performed by flowing large number
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(approximately thousands) of cells per sec through a laser beam. The properties of the
cells such as their size, complexity, granularity, phenotype as well as their health is
evaluated by gathering and analyzing the light emerging from each individual cells.

f luid ic System

Electronics

Figure 3.11 Schematic of flow cytometer showing the major four components - fluidic
system, laser(s), optical system and the electronics for data analysis. (BD biosciences)

A typical flow cytometer has four major components which are briefly discussed
below
Fluidic system

A flow chamber or flow cell transports the cells through a laser to detect
scattering and fluorescence emerging from the cells. The flow cell consists of a narrow
channel through which the cells are injected under pressure surrounded by a sheath fluid.
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The fast flowing sheath fluid imparts huge drag in the flow cell which causes the cells to
flow as a single stream. This effect is also called as hydrodynamic focussing.
Laser system
When the laser is incident on the flowing cells, light is refracted and scattered in
all directions. The amount of light refraction or scattering is dependent on the physical
properties of the cellular population such as the size and the shape as well as the internal
complexity such as granularity, membrane, nucleus material.

(a)

(b)

Figure 3.12 Schematic of light scattering and refraction of a cell flowing through the flow
cell. (a) forward scatter, and (b) side scatter from individual cell (BD biosciences).

The scattering of the light is analyzed at two angles- forward scatter (FSC) and
side scatter (SSC). The FSC is the light scattered in the direction of the laser excitation
on the flowing cells population (Figure 3.12a). Smaller cells produce small amount of
forward scatter while larger cells produce large amount of forward scatter. Therefore, a
histogram of the FSC is a measure of the surface area or the size distribution within a
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population of cells. In the SSC, the light scattered by the cells at larger angles (i.e. to the
side) are collected by focussing using a lens system usually at a right angle to the laser
path {Figure 3.12b). SSC provides a measure of the granularity and internal complexity in
the flowing cell population. A two dimensional histogram of the FSC and SSC data of the
cell population is plotted as a dot or scatter plot. A dot plot of a typical blood sample is
shown in the Figure 3.13 with each dot representing a cell in the population. For a typical
blood sample, the smaller lymphocytes appear to the lower left on the x axis (Rl- red)
while the larger monocytes (R2- green) and granulocytes (R3- blue) are distinguished
based on SSC data on the y axis.
Optical system
The laser system of a typical flow cytometer consists of an argon ion laser
nm emission) and a red diode laser

(~

(~

488

635nm emission) used to excite the fluorescent

antibodies used to label cells. The fluorescent antibodies can bind to specific molecules
on the cell surface or inside the cell. The antibodies are selected in such a way that their
peak emissions are not too close to each other during laser excitation. The most widely
used antibodies are fluorescein isothiocyanate (FITC) , peridin chlorophyll-a (perCP),
phycoerythrin (PE), and allophycocyanin (APC) conjugated antibodies. The 488 nm and
the 635 nm laser excitation beams are combined and focussed on the cells using a
focussing lens. The FSC data is collected using the FSC diode while the SSC data along
with the fluorescence signals are collected using a collection lens at right angle to the
laser beam. A series of optical filters and dichroic mirrors are used to spectrally split the
fluorescence signal which is collected by a photo multiplier tubes (PMTs). Different
subpopulations of the cells from the total cells can be separated out by simultaneous
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labelling with different fluorescent antibodies. Typically, along with the

FSe

and

sse

data, the fluorescence signal from a given subpopulation is used to determine the cell
types as well as their percentages in the total cell sample .
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Figure 3.13 Representative dot plot from a typical blood sample showing three distinct
cell populations depicted as three regions. Rl (red) represent the lymphocytes, R2 (green)
represents the monocytes and R3 (blue) represents granulocytes.

Electronics

The electronics in the flow cytometer convert the light signals into voltage pulses using
photodetectors such as photo diodes or photomultiplier tubes (PMTs).The voltage pulses
are analyzed and quantified by signal processors to determine parameters like pulse
width, height and area The different sUbpopulations in the sample are isolated into
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subsets by creating graphical or numerical boundaries also known as gates. Softwares
such as Cell Quest Pro or WinMDI are used to analyze and plot the data either as 2D-dot
plots or histograms. A detailed schematic of the optical system layout for a BD FACS
Calibur™ flow cytometer system is shown in the Figure 3.14.

Figure 3.14 Schematic ofBD FACS calibur flow cytometer system showing the optical
system layout. (BD biosciences)

3.7 EXPERIMENTAL SECTION
In this dissertation study, the lffiIllune response of the blood leuckotyes to

SWCNTs is evaluated by studying the interactions of the different subpopulations of the
leukocytes to SWCNT using flow cytometry. The two different interactions recreated in
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this dissertation - direct interaction and an indirect interaction of the SWCNTs with
blood will be discussed in the following sections.
3.7.1 Direct interaction of SWCNTs with blood
In the direct interaction study, the response of leukocytes in the blood when they

are in direct contact with SWCNTs is evaluated. SWCNTs suspended in ss-DNA are
added directly to Iml whole blood and incubated for 2 hours at 37°C in 5% CO2
incubator. The positive control for this study is blood mixed with PMA at a concentration
of ~ 100ng/ml incubated for 2 hours at 37°C. PMA, widely known potent tumor promoter
is used to activate the leukocytes in the blood. 1o l Whole blood alone without SWCNTs or
PMA is used as negative control. After 2 hours, blood leukocytes are isolated using
Nl4CI lysis procedure and their response to SWCNTs is evaluated relative to negative
controls (whole without SWCNTs) and positive controls (PMA) using flow cytometry
analysis. Briefly, following the Nl4CI lysis, the cells are resuspended in 1% HAB
solution and split into three tubes (lymphocytes, monocytes and granulocytes) each with
lOOll1 of cell solution. The cells solution is mixed with 100 III of 1% HAB solution and
labeled with 10 III each of fluorescently labeled antibodies as described previously. After
30 minutes of incubation at 4°C, the cells are washed and resuspended in 250 III with 1%
HAB solution for flow cytometry analysis. Cells are visualized using PerCP, FITC, PE
and APC conjugated antibodies against leukocyte phenotype and activation cell-surface
markers. The phenotype and activation markers are selected based on previous studies
performed with analysis of leukocytes in response to bacterial stirnulation 102, burn and
trauma injuries l03 and sickle cell disease l O4 • The list of the fluorescently labelled

so

phenotype and activation markers used for all the different leukocyte subpopulations is
given in the Figure 3.15 .

•
Cell type

Phenotype
FITC/FL 1

Activation
PE/FL2

APC/FL4 PerCP/FL3

Lym phocytes

CD1a

Monocytes

CD11b

CD18

Granulocytes

CD11b

CD18

CD69

CD69

Figure 3.15 Phenotype (blue) and activation (grey) markers used to label the different
subpopulation of blood leukocytes.

Lymphocytes are discriminated using FSC and SSC plots and are phenotyped into
three distinct subpopulations using CD3/CD4 markers. The CD3+CD4+ represent the T
helper! lymphocytes (Th1), CD3+CD4- represent the T helper 2 lymphocytes (Th2) and
CDTCD4- lymphocytes includes the B lymphocytes and Natural Killer (NK) cells.
Monocytes and Granulocytes are discriminated using FSC and SSC and are phenotyped
using CD14 and CD66b markers respectively. The expression of the different activation
markers used for lymphocytes CD69 and CDla; integrins CDllb, CD18 and human
leukocyte antigen - DR (HLA-DR) or major histocompatibility complex 11 (MHC 11) for
monocytes; integrins CDllb, CD18 and CD69 for granulocytes is evaluated using flow
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cytometry. Flow cytometry data files are analyzed using WinMDI software (Scripps
Institute). Each data file is manually gated and analyzed using different combinations of
phenotype and activation markers. Histograms representing the mean fluorescence
intensity (arbitrary units) for the specific activation markers for all the different
subpopulations relative to their controls are plotted. All the data is represented as the
percentage of cells phenotyped using certain phenotype markers (+1-) expressing high
levels of the activation marker. The sample size for all the experiments is n = 4 and data
is represented as means of percentage of cells ± SEM (standard error of mean). Statistical
data analysis of the activation of the cells is scored using a rank sum test (Mann Whitney
U test) with a p value less than 0.05.
3.7.2 Indirect interaction of SWCNTs with Blood
The second study focuses on the interaction of blood cells with APCs containing
SWCNTs. This study attempts to mimic the mechanism of presentation of foreign
antigens to lymphocyte populations by macrophages and dendritic cells. The monocytes
isolated from the whole blood are cultured with and without SWCNTs as mentioned
previously. After 4 days, the cells are trypsinized and resuspended in cell culture
medium. The cells are then mixed with fresh samples of 1 ml whole blood respectively
and kept on a gentle shaker platform for 30 minutes to extensively mix the blood with the
macrophages. After mixing, the blood with the cells is incubated for 6 hours at 37°C in
5% CO2 incubator. After 6 hours, the leukocytes from the blood are isolated using NRtCI
lysis, stained with the activation markers. The phenotype and activation markers used in
this study are the ones used in the direct interaction study. The controls used in this study
are whole blood without macrophages and whole blood with macrophages without
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internalized SWCNTs. The expression of the activation and phenotype markers are
analyzed using flow cytometer as described in the previous section. All fluorescence
expressions are normalized using controls and are represented as mean fluorescence
intensity (MFI) in arbitrary units. The sample size for all the experiments is n

=

4 and

data is represented as means of percentage of c:ells ± SEM (standard error of mean).
Statistical data analysis of the activation of the cells is scored using a rank sum test
(Mann Whitney U test) with a p value less than 0.05. All the data are plotted as
histograms in the same way as in the direct interaction study.
The next chapter deals with the results obtained from the direct and indirect interaction
experiments discussed above. The maturation of monocytes into macrophages and results
from the flow cytometry data for all the different subpopulations of the blood leukocytes
will be shown.
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CHAPTER IV- RESULTS AND DISCUSSION

4.1 RESULTS

This chapter deals with the results obtained from the monocyte/macrophage
maturation study, SWCNTs: ss-DNA cell internalization study and direct and indirect
interaction of SWCNTs with blood leukocytes.
4.1.1 Monocyte Isolation and Maturation into APC Phenotype

Monocytes are isolated from whole blood are cultured in tissue culture flasks for
0, 2, 4 and 6 days in cell culture medium. The differentiation of monocytes into a
macrophage/dendritic cell (APC) phenotype following culture is evaluated using the
maturation marker CD83 (PE labelled) using flow cytometry. The percentage of cells
with high expression of CD 83+ is quantified and plotted for the different time points. It is
observed from the analysis of maturation marker CD83 that on day 2 only 20% of cells
showed high expression whereas on day 4, more than 50% of cells expressed high levels
of CD83 (Figure 4.1). Therefore, the monocytes which matured into macrophages after 4
days are used the APCs for the subsequent experiments.
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Macrophage Maturation

80
70
.!!l
Q3

()
.J::.

60
50

Cl

:.c("')
c:o

40

()

30

0

~
0

•

20
10
0
0

2

4

Time (days)

Figure 4.1 Monocytes/macrophage maturation study. SWCNTs internalized monocytes
are tracked for using maturation marker (CD 83). The percentage of CD83 high cells is
shown for a sample size of 4. 105

4.1.2 Internalization of SWCNTs:ss-DNA
The monocytes isolated are cultured with SWCNTs functionalized with
fluorescently labelled ss-DNA. After 6 hours, the cells are imaged under confocal
microscopy to confirm the internalization of SWCNTs using the green fluorescence from
the FAM-Q fluorescent dye attached to the ss-DNA. It is observed that the cells readily
internalized the SWCNTs:ss-DNA via endocytosis like uptake mechanism as observed
from the strong green fluorescence signal emerging from the cells. A representative
confocal fluorescence image of single monocytes with and without SWCNTs is shown in
the Figure 4.2.
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Figure 4.2 Confocal mIcroscopy unages of single monocytes with and without
internalized SWCNTs:ss-DNA. Phase contrast and fluorescence images of cells (A), (B)
without SWCNTs (control) and (C), (D) with SWCNTs functionalized with FAM-Q
labelled ss-DNA. All the images are obtained at 60x magnification. lo5

4.1.3 Direct interaction of SWCNTs with blood

The response of blood leukocytes to ss-DNA functionalized SWCNTs is
evaluated in comparison to negative controls (without SWCNTs) and positive controls
(PMA) using flow cytometry analysis. The three different subpopulations of lymphocytes
(CD3+CD4+, CD3+CD4- and CD3-CD4-) are evaluated for high levels of expression of

56

activation markers CD69 and CDla respectively. The expreSSIOn of the activation
markers relative to their respective controls is plotted as intensity histogram plots where
the y-axis shows the number of events or the cell count and the x-axis (log) represents the
mean fluorescence intensity of each of the activation markers (Figure 3.15). An increase
in the fluorescence intensities of activation markers in the histograms represents increase
in the activation of the different cell subpopulations. Flow cytometry analysis performed
on a representative sample for the three different sUbpopulations of lymphocytes is shown
in Figure 4.3. It is observed that the SWCNTs samples do not show increased activation
in comparison to whole blood (negative control) for all the different subpopulations of
the cells. However, analysis of the PMA stimulated (positive control) samples showed
increased activation particularly for markers CDla and CD69 on all lymphocyte
subpopulations relative to whole blood (Figure 4.4). Further, monocytes and granulocytes
are discriminated using FSC and SSC and are phenotyped using CD 14 and CD66b
respectively. The evaluation of the high levels of expression of the activation markers
CDl1b, CDI8, HLA-DR on CDI4+ monocytes and CDllb, CD18 and CD69 on
CD66b+ granulocytes is performed using the fluorescent intensity overlay histograms
relative to respective controls.

It is observed that SWCNTs stimulated samples do not show any increased
activation in comparison to whole blood (negative controls) both for the monocytes
(Figure 4.5A) and granulocytes (Figure 4.6A). However, increased activation is seen for
the PMA (positive control) stimulated sample particularly for markers CD 11 b, CD 18 and
CD69 on granulocytes (Figure 4.6B) and to a certain extent for CDllb, CD18 on
monocytes (Figure 4.5B). Furthermore, the percentage of cells expressing high levels of
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the activation markers for all the different subpopulations of blood leukocytes are
quantified from the flow cytometry data (Table 1). Cell activation is scored by
performing statistical analysis of the flow cytometry data using a rank sum test with a p
value less than 0.05 and a sample size of 4.
Statistical analysis of the data in Table 1 showed that when the unstimulated
(whole blood) and ss:DNA functionalized SWCNTs stimulated samples are compared,
there is no statistically significant difference in the expression of any activation marker
for any of the leukocyte subpopulations. However when the unstimulated samples are
compared to samples stimulated with PMA, the expression of several activation markers
particularly CD69 on CD3+CD4+ and CD3+CD4- lymphocytes, HLA-DR on monocytes
and CD 11 b and CD 18 on granulocytes all showed statistically significant changes.
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Figure 4.3 Direct interaction of SWCNTs with lymphocytes in the blood. Representative
sample comparing expressions of CDla and CD69 on (A) CD3+CD4+ lymphocytes, (B)
CD3+CD4- lymphocytes and (C) CD3-CD4- lymphocytes in whole blood (negative
control) vs. SWCNT-stimulated cells. All histograms represent mean fluorescence
intensity (arbitrary units) for the specific activation marker. lOS
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Figure 4.4 Direct interaction experiment lymphocytes controls. Representative sample
comparing expressions of CDla and CD69 on (A) CD3+CD4+ lymphocytes, (B)
CD3+CD4- lymphocytes and (C) CD3-CD4- lymphocytes in whole blood (negative
control) vs. PMA (positive control) stimulated cells. All histograms represent mean
fluorescence intensity (arbitrary units) for the specific activation marker. lOS
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Figure 4.5 Direct interaction of SWCNTs with monocytes in the blood. Representative
sample comparing expressions of CDllb, HLA-DR and CD18 markers on CD14+
monocytes in (A) whole blood (negative control) vs. SWCNTs-stimulated and (B) whole
blood (negative control) vs. PMA-stimulated (positive control) blood samples. All
histograms represent mean fluorescence intensity (arbitrary units) for the specific
activation marker. 105
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Figure 4.6 Direct interaction of SWCNTs with granulocytes in the blood. Representative
sample comparing expressions of CD 11 b, CD 18 and CD69 markers on CD66b+
granulocytes in (A) whole blood (negative control) vs. SWCNTs-stimulated and (B)
whole blood (negative control) vs. PMA-stimulated (positive control) blood samples. All
histograms represent mean fluorescence intensity (arbitrary units) for the specific
activation marker. 105
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Cell type

Blood

SWCNTs

PMA

Lymphocytes CD3+ CD4+ ,CD 69mgn

1.10±O.21

1.26±O.66

67.93±14.18

[Lymphocytes CD3+ CD4+ ,CDlanlgh

O.92±O.23

3.37±2.67

4.90±2.31

!Lymphocytes CD3+ CD4- ,CD 6901gn

5.58±1.47

9.64±7.24

72.47±4.10

!Lymphocytes CD3+ CD4- ,CDlaOign

7.16±3.09

9.71±7.62

18.61±5.17

!Lymphocytes CD3- CD4- ,CD 6901gn

21.24±21.16

18.13±18.11

10.37±4.25

Lymphocytes CD3- CD4- ,CDlaOign

22.07±22.05

19.52±19.46

O.51±O.38

Monocytes CDI4+ HLAlDRDlgh

72.37±4.17

75.05±2.06

30.37±8.91

Monocytes CDI4+ CDllbnlgh

82.68±6.36

79.04±5.39

58.44±1O.23

lMonocytes CD14+ CD18 01gn

82.08±5.93

79.49±5.29

57.95±9.63

lGranulocytes CD66b+ CD 11 bOign

39.01±20.16

55.83±15.31

91.83±6.29

IGranulocytes CD66b+ CD 18 nlgn

33.94±21.96

41.99±20.77

89.94±6.73

K'Jranulocytes CD66b+ CD69 nlgn

24.77±24.75

24.83±24.8

15.49±15.1O

Table 1. Direct response of blood leukocytes to SWCNTs and PMA. All data is expressed
as % of cells ± SEM of a particular phenotype (+/-) expressing high levels of an
activation marker (n = 4).105

4.1.4 Indirect interaction of SWCNTs with blood
In the indirect interction study, the interaction of the blood leukocytes with APCs
(macrophages) containing SWCNTs: ss-DNA is evaluated. The activation of the blood
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leukocytes due to the presentation of SWCNTs by the macrophages is investigated.
Different subpopulations of the blood leukocytes are discriminated using FSC, SSC and
the phenotype markers. Furthermore, the same panel of activation markers, CD69 and
CDla on all three lymphocyte populations; CDllb, CD18 and HLA-DR on monocytes;
CD II b, CD 18 and CD69 on granulocytes are evaluated. The expression of each of the
activation markers for all the different subpopulations is plotted as fluoresce intensity
histograms with respect to their controls (blood without macrophages and blood with
macrophages without SWCNTs). Flow cytometry analysis performed on one
representative sample is shown in Figure 4.7 for lymphocytes and Figure 4.8 (A, B) for
monocytes and granulocytes respectively. It is observed that there is no increased
activation in the cells with SWCNTs internalized macrophages in comparison to the
controls for all the different lymphocytes, monocytes and granulocytes subpopulations.
Cell activation is scored by performing statistical analysis of the flow cytometry data
using a rank sum test with a p value less than 0.05 and a sample size of 4 (Table 2).
Statistical analysis of the data in Table 2 showed no statistically significant difference in
the expression of activation markers on any of the leukocyte subpopulations stimulated
with mature macrophages without SWCNTs or mature macrophages SWCNTs in
comparison to the samples that are not mixed with macrophages.
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Figure 4.7 Indirect interaction of SWCNTs with lymphocytes in blood. Representative
sample comparing expressions of CDla and CD69 on (A) CD3+CD4+, (B) CD3+CD4and (C) CD3-CD4- lymphocytes in whole blood, stimulated with macrophage without
SWCNTS and macrophages with internalized SWCNTS. All histograms represent mean
fluorescence intensity (arbitrary units) for the specific activation marker. lOS
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Figure 4.8 Indirect interaction of SWCNTs to monocytes and granulocytes in blood.
Representative sample comparing expressions of (A) CDllb, HLA-DR and CD18 on
CD 14+ monocytes and (B) CD 11 b, CD69 and CD 18 on CD66b+ granulocytes in whole
blood, stimulated with macrophage without SWCNTS and macrophages

with

internalized SWCNTS respectively. All histograms represent mean fluorescence intensity
(arbitrary units) for the specific activation marker. lOS
66

Blood w/o
Macropbages

Blood +
Macropbages
w/oSWCNTs

Blood +
SWCNTs
Internalized
Macropbages

Lymphocytes CD3+ CD4+ ,CD 69high

2.65 ± 1.81

2.75±1.51

3.87 ± 2.75

Lymphocytes CD3+ CD4+ ,CDlahigh

1.61 ± 0.95

1.01 ± 0.35

0.53 ± 0.39

Lymphocytes CD3+ CD4- ,CD 69high

3.88 ± 2.54

5.32 ± 3.37

3.25 ± 2.21

Lymphocytes CD3+ CD4- ,CDlahigh

0.69 ± 0.44

1.91 ± 1.14

2.81 ± 2.32

Lymphocytes CD3- CD4- ,CD 69high

1.48 ± 1.10s

1.51 ± 0.93

1.02 ± 0.59

Lymphocytes CD3- CD4- ,CDlahigh

0.315 ± 0.26

0.52 ± 0.42

2.10 ± 2.04

Monocytes CD14+ HLAlDRhigh

42.65± 15.25 34.02± 12.78 45.17± 14.24

Monocytes CD14+ CDllbhigh

54.16 ± 17.1

42.34± 16.23 49.51± 15.4

Monocytes CD14+ CDlShigh

33.4 ± 19.14

24.64 ± 14.1

32.89± 18.41

Granulocytes CD66b+ CD 11 bhigh

72.34± 21.61 80.77 ± 17.1

77.97± 19.94

Granulocytes CD66b+ CD IS high

23.21± 23.04 24.1± 26.63

24.26± 23.84

Granulocytes CD66b+ CD69high

1.64 ± 1.51

4.22 ± 4.1

Cell type

6.83 ± 6.69

Table 2. Indirect response of blood leukocytes to SWCNTs in comparison to whole
blood, stimulated with macrophage without SWCNTS and macrophages with internalized
SWCNTS. All data is expressed as % of cells ± SEM of a particular phenotype (+1-)
expressing high levels of an activation marker (n = 4).105
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4.2 DISCUSSION

Carbon nanotubes are widely used for various applications in cell and molecular
biology due to their unique physical and structural properties. 5, 29-31, 33-35 Several studies
have reported on the great potential of CNTs in transporting various biomolecules like
antibodies, proteins and nucleic acids into the cytoplasm and potentially into the
nucleus. 6o, 62,

70, 71, 106

Several reports exists on the cellular level toxicity of CNTs in a

variety of mammalian cells including leukocytes isolated from blood; however while
majority of these studies reported minimal changes to cell structure and function 85 -87 ,
some studies observed changes in cell signalling processes due to CNTs. 107,

108

Cell

culture models provide limited information regarding the systemic response of the body
due to the presence ofCNTs.
In this dissertation, blood is chosen as an appropriate tissue culture model to
thoroughly investigate the response of the SWCNTs in the human body. Blood is a living
tissue and plays a major role in immune homeostasis. Therefore, the response of the body
to SWCNTs can be evaluated by studying the changes in the inflammatory status of the
cellular populations (specifically leukocytes) in the blood. Due to the limited stability of
the blood cells in vitro(- 6 hours), the studies are limited to investigating the acute
response of blood to SWCNTs. The acute immune response is investigated by extracting
blood samples and studying the interactions of SWCNTs with blood leukocytes. Two
possible types of interactions of SWCNTs with blood are recreated - direct interaction
and indirect interaction. The direct interaction mimics the presence of SWCNTs in blood
circulation while the indirect interaction recreates the presentation of SWCNTs to the
blood leukocytes via APCs. The direct interaction study is analogous to the innate
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immune response while the indirect interaction study is analogous to the adaptive
immune response which occurs in the human body in response to foreign antigens. The
activation markers chosen for monocyte and granulocyte subpopulations are integrins and
MHC II (HLA-DR) molecules that the cells express in response to any foreign antigens.
As mentioned in chapter III, integrins help in adhesion of leukocytes to endothelium and
promote transmigration into site of tissue inflammation, which is a defining event in the
early activation of monocytes and granulocytes. The activation markers chosen for
lymphocytes are cell surface molecules that are upregulated following their interaction
with APCs like macrophages and dendritic cells. Therefore, by evaluating the expression
of the integrins, MHC II and cell surface molecules, the immune response of all the
different subpopulations of the blood leukocytes can be very well understood. Any
activation of leukocytes due to SWCNTs is reflected as changes in the expression of
these activation markers.
Results from the direct interaction of SWCNTs with blood showed that there is no
increased expression of the activation markers relative to the negative control for the
different lymphocyte, monocyte and granulocyte subpopulations. However, the tumor
promoter, PMA stimulated samples (positive control) show distinct increase in the
expression of most of the activation markers for the different sUbpopulations of the cells.
These results are further corroborated using the statistical rank sum test which indicates
no statistically significant difference in the expression of the activation markers on the
SWCNTs samples versus the blood (negative control) samples. These results indicate
minimal activation of blood leukocytes following their direct interaction with SWCNTs.
Thus, the leukocytes do no initiate an immune response due to the presence of SWCNTs
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in the blood circulation. In the indirect interaction of SWCNTs with blood, the results
obtained showed that there is no increase in the expression of any of the activation
markers for all the different leukocyte subpopulations. The expression of the activation
markers for the leukocytes samples stimulated with SWCNTs internalized macrophages
is very similar to the samples stimulated with macrophages without SWCNTs and
samples without any macrophages. The statistical test further confirmed that there is no
statistically significant difference in the expression of the activation markers on all
leukocyte subpopulations in all the three different samples. These results indicate
minimal activation of blood leukocytes following their interaction with SWCNTs via
APCs. Thus, the presentation of SWCNTs by the APCs to the blood leukocytes does not
initiate an immune response from the leukocytes. Though the long-term effects are not
observed, this thorough study provides a good starting point in trying to evaluate
leukocyte activation in response to SWCNTs in the body. The ss-DNA used to
functionalize SWCNTs serves two purposes. Firstly, it as a surfactant preventing
aggregation in the suspension medium and secondly, it provides a highly flexible
backbone for further functionalization with biomolecules targeting specific groups on the
5' and 3' ends of the strand. Further, the intracellular delivery ofss-DNA using SWCNTs
is relevant to gene and drug delivery applications. The results demonstrate minimal acute
immune response from blood leukocytes and support the pursuit of CNTs based
approaches for delivery of genes and biomolecules to cells.
4.3 SUMMARY

This concludes the first part this dissertation in which the use of CNTs for
biomedical applications is discussed. The toxicity of CNTs and their potential to elicit an
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immune response from blood leukocytes is evaluated. This is achieved by recreating, in
vitro, two types of interactions that potentially occur in the body - (a) direct interaction:

due to the presence of CNTs within the body and (b) indirect interaction: due to the
presentation of CNTs via APCs to the blood leukocytes. Blood leukocytes are isolated
and evaluated for the expression of early activation markers. The results indicate minimal
leukocytes activation following both types of interactions. The potential of CNTs to
transport of various biomolecules like genes and drugs across the cell membrane is also
demonstrated by delivery ss-DNA. The results support the pursuit of CNTs based
approaches for delivery of genes and biomolecules to cells.
The next part of this dissertation discusses semiconductor nanocrystals or
quantum dots (QDs) for the intracellular labelling and tracking of subcellular
biomolecules.
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CHAPTER V- COLLOIDAL QUANTUM DOTS

5.1 INTRODUCTION

Semiconductor nanocrystals or quantum dots (QDs) are inorganic semiconductor
particles with diameters ranging from a few nanometers to hundreds of nanometers that
possess size dependent electronic and optical properties I 09-112. At a given temperature, the
size below which variation in the fundamental electrical and optical properties occurs
when the energy level spacing exceeds the temperature is large in the case of
semiconductors than in metals, insulators or molecular crystals. In metals, the fermi level
lies in the center of a band and there is very small energy level spacing, and at few kT,
the electrical and optical properties resemble that of continuum even in small sized
nanocrystals I13 . However, in semiconductors, fermi level lies between two bands and the
band edges dominate the low energy optical and electrical properties. (Figure 5.1) The
size dependent properties of these nanocrystals are a result of two major factors. Firstly,
the number of atoms on the surface is a large fraction of the total number. Secondly, the
fundamental properties of these nanocrystals are determined by quantum confinement
effect.
5.2 QUANTUM CONFINEMENT

In a semiconductor material, the superposition of wave functions and energy
states of all the atoms result in the band structure. The minimum energy required to excite
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an electron into the vacant conduction band leaving behind a hole in the filled valence
band is the band gap energy, Eg.
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Figure 5.1 Density of states comparison of (A) metal and (B) semiconductor nanocrystals
with respective bulk materials. The density of states is discrete in both metals and
semiconductors near the band edges. In metal nanocrystals, as fermi level lies in the
center of band, a few kT is greater than the energy level spacing and hence it resembles
continuous states even for small sizes. However, in semiconductor nanocrystals, as the
fermi level lies in between two bands, the energy level spacing is large even at large sizes
and the energy gap increases in semiconductor nanocrystals of smaller size. IID
Typically, the electronic transitions in the semiconductor material determine its
optical properties. An exciton is created when the electron-hole pair is electrostatically
bound. Radiative recombination can occur when the excited electron relaxes back to the
valence band by emitting a photon. The size of the exciton varies from a few to few
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hundreds of nanometers and is defined by Bohr exciton radius (a ex ). The radius of the
exciton is defined by a physical constant called Bohr radius (aB), the approximate
distance between the electron and proton in a hydrogen atom in its ground state.
(Equation 5.1)

Equation 5.1 Formula for Bohr radius aB, where Co is the permittivity of free space, h is
the reduced Planck's constant, me is electron rest mass, e is the charge.
The exciton Bohr radius (a ex ) is obtained by scaling the Bohr radius (aB) with dielectric
scaling factor. (Equation 5.2)

Equation 5.2 Formula for exciton Bohr radius,a ex , where J1. is the exciton reduced mass,
K

is the dielectric constant of the semiconductor.

When the size of the semiconductor approaches the exciton Bohr radius or the de-Broglie
wavelength, quantum confinement effects are observed. The de-Broglie wavelength i!. is
given by the following equation

h
h
i!. - - - --;:::::;;::::::::=
- p - .J3kTmett
Equation 5.3 The de-Broglie wavelength i!. depends on the effective mass mett of the
carrier (electron or hole) in the crystal not the free electron mass and also on the
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temperature T. The effective mass in the crystal is much smaller than the free electron
mass.
In the late 1950s and early 1960s, research has mainly focused on fabricating
ultra-thin films of semimetals like bismuth for studying the size quantization effects.114
Lustkii et al. and Filatov et al. have observed the effect of the increase in the band gap
with decreasing thickness of Bi and InSb films. I IS, 116 However, most of the work during
that time was theoretical due to the limited availability of technology to fabricate high
quality interfaces. The possibility of observing size quantization effects are reduced due
to rough or defective interfaces. In the late 1960s, development of novel epitaxial
deposition techniques such as molecular beam epitaxy and metal organic chemical vapor
deposition led to the fabrication of multilayer periodic semiconductor heterostructures.
Now, it is experimentally well established that the size and shape of a semiconductor can
. eIectromc
. an d optIca
. I propertIes.
. 117' 118
on Its
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5.3 ELECTRONIC STRUCTURE OF QDS
In bulk semiconductor or 3D system, the exciton can move freely in all
directions. If the material size is reduced in one dimension i.e., the exciton can move
freely in only two dimensions, the resultant structure is referred to as quantum well (QW)
or 2D well. In this case, the electrons behave like electrons in a potential well and have
discrete energy levels due to quantum mechanical confinement. Quantum wells were
formed by inserting very thin layers (approximately few lattice constants thick) of a
lower bandgap semiconductor in a matrix with larger bandgap. One of the first quantum
wells were fabricated in the GaPxAsl_x/GaAs material system in early 1970s by Noble
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pnze wmner Alferov. 11 9 By the end of 1980s, the fundamental properties of these
quantum wells were well understood and the research focused on fabricating structures
with further reduced dimensionality. 120 If the exciton is confined in two dimensions and
is free to move in only one dimension, then it is termed as quantum wire (QWR) or ID
wire. In the case of quantum dot (QD), the exciton is restricted in all three dimensions
and the confinement is more pronounced than the QW or the QWR case. They are
referred to as OD structures as the carriers are completely confined in all three dimensions
which results in discrete energy levels as in the case of the electron in a hydrogen atom.
A comparison of a 3D bulk material with a 2D quantum well, aID quantum wire and a
quasi OD QDs is shown (Figure 5.2).

z

~

c)

b)

Figure 5.2 Schematic of (a) 3D or bulk, (b) 2D or quantum well, (c) ID or quantum wire,
and (d) OD or quantum dot is shown. I 17. 11 8
Band structures of materials are calculated usmg free electron or KroningPenney or tight-binding models and effective mass and pseudopotential methods. The
number of allowed energy states in the band structure are defined by the density of states
(DOS). The densities of states are strongly influenced by quantum confinement effects as
shown in the Figure 5.3. In bulk or 3D system, the DOS is continuous as the carriers are
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free to move in all directions. In the case of quantum well or 2D system, the carriers are
confined in one dimension and thus DOS resemble a step function like behavior.
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Figure 5.3 Densities of states of (a) 3D or bulk, (b) 2D or quantum well, (c) ID or
quantum wire, and (d) OD or quantum dot. The DOS is continuous in bulk, a step
function in QW, has peculiarities in QWR and a delta function in QDS. 117
In the case of quantum wire or 1D wire, the DOS has a peculiarity also referred to
as Van-Hove singularities. In the case of QDs or OD structures, the carrier localization
occurs in all three dimensions which results in the breakdown of the classical band
structure model. This strong quantum confinement results in very discrete energy states
in the band structure of single QD similar to atomic energy states. This dissertation deals
with such semiconductor nanocrystals or QDs.
In addition to the electronic properties, the quantum confinement affects the
optical properties of these quantum confined structures. The optical absorption and
emission properties of these structures are very different from the bulk materials. The
exciton levels of the QD are given by solving the classical quantum mechanical problem
of particle in a box. The minimum energy required to excite an electron from the valence
band to the conduction band in the QD is given by
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Equation 5.4 The lowest excited electronic state of a quantum dot is given by E, where Eg
is bulk band gap energy, h is the reduced Planck's constant, me and mh are the effective
mass of the electron and hole, e is the electron charge,

E

is the dielectric constant and r is

the radius of the quantum dot.
As shown in the equation 5.4, the excited energy state of the QD is dependent on
the band gap, the dielectric constant of the bulk material and on the size or radius of the
QD. The second term in the equation 5.4 is quantum localization energy for electron and
hole which increases with decreasing size as 1/r2. The third term in the equation 5.4
represents the Coulomb energy which is a function of 1Ir. It can be seen that for large
radius the Coulomb interaction is dominant than the quantization energies ofthe electrons
and hole. In the case of small radius the Coulomb interaction is less important and the
quantization energies dominate. Thus the optical properties not only depend on the
composition of the material but also on the size and the shape of the QD. As the radius of
the QD decreases, the spacing between the discrete energy levels increases resulting in
blue shift in the optical emission spectrum (Figure 5.3). In other words, the smaller the
dot, the more blue shifted is the fluorescence emission and the larger the dot, the more
red shifted is its fluorescence emission.
5.4 SYNTHESIS OF QDS

During the early 1930's, Rocksby first realized QDs as nanometer sized
semiconductor crystal inclusions in glass which are commercially available for decades
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as color filters.l2I It was only in the early 1980's, QDs synthesis was described by Efros
et al. and Ekimov et al. who experimentally confirmed the quantum confinement effects
in such colored glass matrices by growing semiconductor nanocrystals and microcrystals
in glass matrices. 122,

123

Since their work, techniques to synthesize of QDs received

substantial attention and extensive research efforts. Early research to fabricate QDs
focused on patterning quantum wells using high resolution lithography techniques. 124. I27
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Figure 5.4 Comparison of discrete energy levels of two different QDs with (a) large
radius and (b) small radius. As the size of the quantum dot decreases, the energy level
spacing increases. 128
However, the etching processes in the fabrication induced defects to the active QD
material with limited attainable resolution. Several researchers have successfully
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fabricated QDs on substrates using epitaxial growth and selective growth metal organic
chemical vapor deposition techniques. 129- 133 These techniques require complex growth
control patterning with low density yield. One of the most widely successful and
exploited epitaxial growth techniques for the fabrication of QDs is the StranskiKrastonow (SK) growth. The SK growth of the QDs is driven by the strain due to lattice
mismatch which results in coherent, i.e. defect-free, three dimensional islands. 134 The
major limitation of this method is the cost of fabrication and the poor control over
positioning of individual dots.
In this dissertation, QDs synthesized using solution chemistry (colloidal QDs) are
discussed. Typically, colloidal suspensions of QDs are synthesized by introducing
semiconductor precursors in the presence of semiconductor binding agents under
thermodynamically favorable conditions for growing crystals. Several methods exist for
the synthesis of colloidal QDs in solution such as synthesis from supersaturated glass
solutions 135, via pyrolysis of organometallic precursors l36 and epitaxial growth
technique.137 Colloidal QDs are generally made from group II and VI elements such as
CdSe and CdTe along with zinc compounds ZnO, ZnSe, ZnS (used only as the shell
material) or from group III and V elements such as InP and lnAs. The size dependent
properties of these QDs are striking when they are monodisperse in solution. Murray et
al. first demonstrated the synthesis of CdSe, CdS and CdTe QDs by injecting
semiconductor precursors to a liquid coordinating solvent at high temperature. 138 The
prepared QDs were approximately 1.2 to 11.5 nanometers in diameter with good
crystalline structure, surface derivatization and a high degree of monodispersity

« 5%

root mean square in diameter). Ever since this seminal work, large efforts were devoted
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to the synthesis of QDs with precise control of the particle size, shape1 39-142 and the
internal structure. 143, 144
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Figure 5.5 (A) La Mer model 145 schematic of the different stages of nucleation and
growth for the synthesis of monodisperse nanocrystals. As the nanocrystals grow with
time, different sized crystals are isolated by periodically removing aliquots from the
reaction chamber, (B). Typical apparatus used in the synthesis of monodisperse QDs
samples. III
In the 1950s, La Mer et al. proposed a model for the synthesis of monodisperse
nanocrystals using a temporally discrete nucleation mechanism followed by slow
controlled growth on the existing nuclei. 145 When the precursors are rapidly injected into
the reaction chamber, their concentration reaches above nucleation threshold as shown in
Figure 5.5A. The resulting supersaturation is partially released by a short burst of
nucleation. No new nuclei are created as long as the rate of decomposition of the
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precursors is not more than the rate of the addition of the precursors. The time for the
formation and growth of the nuclei determine the initial size distribution of the
nanocrystals. Monodispersity is achieved with time if the percentage of the nanocrystals
during the nucleation event is small in comparison to the subsequent growth events. This
phase is referred to as size-focusing point. In many systems, with time another growth
phase called Ostwald ripening 146,

147

occurs in which smaller nanocrystals are dissolved

due to their high surface energy while re-deposition occurs on the larger nanocrystals.
This process dramatically simplifies the production of different sizes of nanocrystals by
periodical removal of aliquots of the samples.
In the case of semiconductor QDs synthesis, metal-organic precursors are rapidly
injected into a hot (~150-350°C) coordinating solvent (Figure 5.5B). The coordinating
solvent consists of tri-n-octylphosphine oxide (TO PO) and tri-n-octylphosphine (TOP) long-chain alkyl phosphine oxides and alkylphosphines which contain the basic functional
groups to bind to the surface of the QD during growth preventing the growth of bulk
materials. The alkyl chains (ligands) render stability to QDs and make them dispersible in
many nonpolar solvents. In a typical CdSe QDs synthesis, dimethylcadimum and
elemental selenium dissolved in liquid TOP are used as precursors. The room
temperature precursors are rapidly injected into the reaction chamber containing boiling
TOPO and stirred vigorously. Rapid, immediate nucleation and growth of CdSe QDs
occurs as it is thermodynamically favorable because the concentrations of the precursors
introduced are higher than the solubility of the resulting material. The growth of the QDs
is kinetically controlled by the monomers diffusion as wen as the reaction rate of the
monomers at the QDs surface. High temperature helps in overcoming the steric, kinetic
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barrier required for the nucleation. Homogenous growth of the nuclei is achieved if the
nucleation is stopped within a short period of time by a quick drop in the temperature and
the monomer concentration. As per the La Mer model, the size distribution of the CdSe
QDs widens after the size-focusing point and Ostwald ripening starts to occur. Aliquots
of the reaction mixture are removed from the reaction chamber periodically to attain
different sizes of CdSe QDs. The presence of the hot coordinating solvent yields in
highly crystalline QDs with reduced lattice defects. The excess solvent and the byproducts of the reaction are removed from the aliquots by isolation and purification
processes. 138,

148

Larger crystals present in the aliquots are precipitated using methanol

and the resulting narrow size distributions of the CdSe QDs are re-dispersed in I-butanol.
The above mentioned method is the most effective and reproducible method for the
synthesis of QDs composed of CdSe as well as other compositions.

144, 149, 150

Diverse

precursors for CdSe QDs such as cadmium oxide, dimethylcadimium and cadmium
acetate combined with TOP-Se and various coordinating solvents such as alkylamine,
alkanoic acids are utilized to enhance the mono dispersity as well as the quantum
yield.ISI-IS3

QDs prepared using the above mentioned synthesis procedure have large surface
to volume ratios with a large surface fraction of the atoms exposed resulting in atomic or
molecular orbitals that are not completely filled. The dangling bonds may bind with the
organic ligands such as TOPO resulting in the passivation of the surface of the QDs that
not only maintains the lattice structure but also protects the surface from external
environment. IIO However, the bond strength between the ligands and the surface is less
than that of the semiconductor lattice which may result in desorption of the ligands
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making the core susceptible to external factors such as heat, UV light and ions. Thus in
order to avoid damage to the core, it is desirable to grow a shell over the core QD surface,
referred to as core/shell QDs. Several modifications of the core surface were investigated
and more commonly inorganic coatings are used as the shell materials. The presence of
the shell not only acts as a physical barrier for core degradation and prevents aggregation,
but also results in stronger electronic insulation increasing the fluorescence efficiency.
Passivation of the QDs core surface with a semiconductor shell did not seem to alter
absorption and emission energies and the quantum yields as high as 50-70% were
observed especially in the case of core/shell structures such as CdSe/ZnS, CdSe/CdS and
ZnSe/ZnS QDS. 136,

137, 154

An additional shell over the core/shell structures were

synthesized in which the middle shell provides strain relaxation between the inner core
and the outer shell, further increasing the fluorescence efficiencies than the core/shell
structures. Some of the core/shell/shell structures are CdSe/CdS/ZnS, CdSe/ZnSe/ZnS
and CdSe/ZnTe/ZnS QDS. 155 , 156
The core/shell QDs are classified based on the band alignment between the core
and shell semiconductor materials. In a type I structure, the shell is made of
semiconductor material with a wider bandgap than the underlying core (Figure 5.6A).
The conduction band edge and valence band edge of the core lies within the bandgap of
shell material which confines the electrons and holes in the core regions where they
recombine quickly. The shell in type I QDs passivates the core by physically separating it
from the surrounding environment. Any change in the local environment has minimal
effects on their optical properties. The fluorescence emission wavelength is slightly redshifted compared to the unmodified core QDs due to partial leakage of the exciton into
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the shell. The most commonly used type I QDs are CdSe/ZnS, CdSe/CdS and InAs/CdSe
core/shell systems. In the case of type II structure, the valence band edge or the
conduction band edge of the shell material is located in the bandgap of the core. This
staggered alignment of the bands results in the electrons and holes being spatially
separated between the core and the shell. This results in longer lifetimes for the excitons
before recombination occurs (Figure 5.6B, C).

Core/Shell

Core/Shell

Core/Shell

A
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B
Type II
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E,!
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o
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Figure 5.6 (A) Schematic of the energy band alignment of (A) type I, (B and C) type II
and (D) Reverse type I core/shell QDs. CB and VB stands for conduction and valence
bands respectively. Eg stands for bandgap of the semiconductor. The solid circle
represents an electron and the empty circle a hole.
In the type II systems, the shell mainly contributes to the red-shift in the
fluorescence emission. Some of the most commonly used type II QDs are CdSe/ZnTe,
CdTe/CdSe, CdS/ZnSe core/shell systems. 157 Another variation of the type I core/shell
system is the reverse type I core/shell QDs, in which a smaller bandgap shell is grown on
a wider bandgap core material (Figure 5.6D). The charge carriers are partially delocalized
in the shell material and the fluorescence emission can be tuned by varying the thickness
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of the shell. Some of the most widely studies systems are CdS/HgS, CdS/CdSe and
ZnSe/CdSe QDS. 158

5.4.1 Surface modification of QDs for biocompatibility
As synthesized QDs are coated with hydrophobic molecules and hence are soluble
in nonpolar organic solvents. It is necessary to solubilize QDs in aqueous solvents to
render biocompatibility for biomedical applications. Two seminal studies successfully
demonstrated water soluble CdSe/ZnS core/shell QDS. 159, 160In one ofthe studies done by
Nie et aI., as synthesized QDs were stabilized in aqueous solution using small thiolate
ligands such as mercaptoacetic acid which binds to the zinc atom while the polar
carboxyl groups render water solubility. The carboxyl groups are used to covalently
attach biomolecules such as proteins, peptides and nucleic acids. Though these QDs are
water soluble, the bonding between the ligand and the QDs is weak, causing rapid
degradation in complex biological environments. In the other study done by Alivisatos
et.al, core/shell QDs are modified with a third silica layer to make them water soluble.
This method had advantages compared to the direct attachment to the QDs surface: as the
multivalency of the extensively polymerized polysilane ensures the solubility of the QDs
despite the potential loss of the thiol groups. In addition to this, the silica chemistry has
been thoroughly investigated and the modified QDs retained fairly large quantum yield.
More recently, several strategies were employed for the production of water soluble
QDSI61. A representative list of the various strategies for capping and dispersing QDs is
shown in Figure 5.7. One of the methods involves exchanging the native TOP/TOPO
ligands with bi-functionalligands, referred to as cap exchange method. The bi-functional
ligands consists of hydrophobic groups at one end like the thiols (-S-H) which bind to the
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surface of the QDs while hydrophilic groups at the other end like the carboxyl groups (COOH) that render water solubility.162-165 For example, CdSe/ZnS QDs are coated with
mercaptoacetic acid and trimethylsiloxane. However, the ligand exchange methods
reduced the fluorescence efficiency of the QDs with a potential to cause aggregation.
More recently, these problems were overcome by preserving the native TOP/TOPO
ligands and covering the hydrophobic QDs with amphiphilic polymers.166-169 Another
strategy involves using silica shells functionalized with polar surface groups to protect
the hydrophilic QDs. 170 The presence of such amphiphilic polymer coatings (silica shells)
increases the size of the QDs, for example in the case of CdSe/ZnS QDs from
before coating to

~20-30

~

4-8 nm

nm. QDs are purified from the residual ligands and excess

polymers via ultracentrifugation, dialysis or filtration methods prior to their use in
biological applications.
5.5 BIOMEDICAL APPLICATIONS OF QDS
5.5.1 Advantages of QDs

Even though QDs are developed for electronics and optics approximately two
decades ago, their potential for biomedical applications was realized only recently. The
ability to synthesize water soluble QDs opened up a plethora of applications for their use
in biology and medicine. Following the two seminal reports l59 , 160 demonstrating the use
of QDs as biological labels, large research efforts were devoted to the development of a
variety of applications for QDs. The unique optical properties of the QDs make them
promising candidates for in vitro as well as in vivo applications.
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QDs offer a number of advantages over traditional biological labels such as
fluorphores or organic dyes. The fluorescence emission is tunable based on size as well
as composition from the ultraviolet to the visible and near-infrared wavelengths. For
example, in the case of CdSe QDs, the fluorescence emission wavelength changes from 475 nm for 2.1 nm diameter to- 650 nm for a 7.5 nm diameter (Figure 5.8).
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Figure 5.8 (A) Size tunable fluorescence emission of CdSe QDs, (B) relative sizes of
QDs with diameters of2.1 nm, 2.5 nm, 2.9 nm, 4.7 nm and 7.5 nm.
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The composition of QDs is modified to tune the fluorescence emission from ultraviolet
wavelengths as in the case of ZnS QDs to near infrared wavelengths in the case of PbSe
or PbTe QDs. Thus, the fluorescence emission can be also be tuned based on the
biological applications as shown in Figure 5.9.
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QDs have very narrow and symmetric fluorescence emtSSiOn spectrum (20-30
nanometers, full width half maximum, FWHM) compared to organic dyes and
fluorescence proteins which have significant red-shift tails. QDs have broad absorption
bands with high molar extinction coefficients (approximately 105_10 7 M-1cm- l ) which is
10-100 times larger than that of organic dyes I72 and large effective stokes shifts (Figure
5.10). This provides the ability to excite a family of different colored QDs with a single

excitation wavelength, thereby providing multiplexing capability.
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wavelengths from ultraviolet to near infrared wavelengths. 161
The large stokes shifts in QDs not only increases the detection sensitivity but also
help in differentiating them in biological samples with high auto fluorescence
backgrounds. In addition to the mentioned advantages, QDs have high resistance to
photo bleaching as well as exceptional resistance chemical degradation. Under similar
excitation, QDs are at least 1000 times more photostable than organic dyes such as Texas
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Red (Figure 5.11). Thus QDs are excellent candidates for tracking based studies over a
long period of time.
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Figure 5.10 Comparison of the absorption (blue) and fluorescence spectra (red) ofCdSe
QDs with fluorescence proteins (mCherry) and organic dye (Texas red). The absorption
spectrum of Q Ds is broad and the emission spectrum is symmetric and narrow. 173
5.5.2 Bioconjugation of QDs
Apart from the advantages, the comparable size of the QDs with many biological
systems such as proteins, antibodies and nucleic acids have led to their extensive use in
various biomedical applications. Water soluble QDs are conjugated with many
biomolecules like proteins, antibodies and other targeting or affinity ligands.
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The QDs: biomolecule conjugates possess the unique spectroscopic properties of the QDs
as well as retain the functional properties of the attached biomolecule. A single QD can
be conjugated to multiple proteins or biomolecules resulting in a multifunctional
nanoparticle-biomolecule hybrid (Figure 5.12). Bioconjugation of QDs is achieved using
standard coupling reactions like passive adsorption, multivalent chelation or through
formation of covalent bonds. Two of the most popular crosslinking reactions are based on
amide bond formation using EDAC (ethyl-3-dimethyl amino propyl carbodiimide) and
amine-sulfhydryl

coupling

using

SMCC

(succinimidyl-4-N -maleimidomethyl-

cyclohexane carboxylate ).175
In EDAC method, QDs containing carboxylate groups are coupled with the amine
groups present of the biomolecules using a single or two step reactions (Figure 5.l3a). In
the single step process, the QDs are activated using EDAC in the presence of amine
containing molecule like proteins. As the proteins contain both the carboxylates as well
as amines, polymerization can occur. A two-step reaction is used to minimize this
polymerization problem. In the first step, EDAC is used in the presence of sulfo-NHS (Nhydroxysulfosuccinimide) which converts the carboxyl groups on the QDs to
intermediate amine-reactive sulfo-NHS esters. Following a quick separation step to
remove the unreactive or excess reactants, the activated QDs are mixed with the protein
solution in a desired molar ratio. This results in amide bond formation without the
polymerization of the protein in the solution. The presence of sulfo-NHS increases the
efficiency of EDAC mediated coupling. The second method for QDs bioconjugation is
based on using sulfo-SMCC, which is a heterobifunctional crosslinking agent with an
amine-reactive NHS ester group at one end and a thiol-reactive maleimide group at the
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other end. Amine containing QDs are activated by converting amines to sulfhydrylreactive maleimides using SMCC which then reacts with thiol-containing proteins or
other biomolecules (Figure 5.13b). The advantage of the EDAC method is that most of
the proteins and biomolecules contain primary amines and carboxyl groups and hence do
not need any further chemical modifications for conjugation. The SMCC method is very
useful in the case of biomolecules which have the free sulfhydryl groups to react with the
amine groups on the QDs. These two methods are used interchangeably depending on the
availability of the reactive chemical groups. The QDs surface is also modified with
hydrophilic molecules like polyethylene glycol to minimize nonspecific binding or to
decrease the clearance rate from the blood stream for in vivo applications.
In another method of QDs bioconjugation, Goldman et al. demonstrated the use of
an adaptor protein for immunoglobulin G antibody coupling. 176 The conjugation method
utilizes an engineered adaptor protein which has a positively charger leucine zipper
moiety which links to the QDs (using electrostatic or hydrophobic self-assembly) and a
protein G domain that binds to the antibody Fc region. The antibody Fc region is
effectively connected to the surface of the QD while the antigen specific F(ab 'h domain
is free to bind to the specific target (Figure 5.12c). A chelating compound like Ni-NTA
(nickel-nitrilotriacetic acid) is also used to bind to the 6-histadine containing
biomolecules. 174 This method is more advantageous as it provides control over the molar
ratios, the orientation of the biomolecules as well as improves the binding efficiency.
Even though the QDs bioconjugation methods involve standard coupling
reactions, some difficulties still exists. Firstly, the buffer and salt compatibility needs to
be taken into account when dealing with QDs. Smaller charged particles typically
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maintain stability in colloidal dispersion by like-charge repulsion which effectively
prevents aggregation by Vander Waals or hydrophobic interactions. Precipitation will
occur if the salts or buffers neutralize the QDs surface charges. It is also important to
consider the optimal number of biomolecules conjugated to each QD. In the case of
antibody-QDs conjugates, two to three antibodies conjugated per QD may be sufficient
while for protein-QDs conjugates, higher ratio of protein to QDs may be necessary. Most
importantly, the correct orientation of the biomolecules, for example, antibodies on the
QDs is necessary. Otherwise the antibodies may not be functional which results in low
avidity.
5.5.3 Applications of QDs

One of the most attractive biomedical applications of QDs is in labeling of cells
and tissues. Several reports have published in using bioconjugated QDs for in vitro as
well as in vivo applications. Chan et ai. was one the first to demonstrate the use of IgG
conjugated QDs for labeling of HeLa cells. 159 The QDs: IgG conjugates were detected by
polydonal anti-IgG and the conjugates were readily uptaken by the cells. In another study
by Mattoussi et aI., a chimeric fusion protein was designed which electrostatically bound
to the oppositely charged surface of the QDS. 162 QDs conjugated to maltose binding
protein-basic leucine zipper (MPB-zp) fusion protein were used to detect the interactions
between the MPB and amylose affinity resin. The addition of free maltose reversed the
binding. The QDs:MPB-zp conjugates preserved the bioactivity of the MPB domain
despite the use of a fusion protein.
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Figure 5.13 Typical methods of QDs bioconjugation. (a) Covalent crosslinking of
antibody with QDs using EDAC chemistry method, (b) conjugation of antibody
fragments using SMCC method, (c) conjugation of QDs using adaptor protein method
and (d) conjugation of Ni-NTA modified QDs with histidine tagged peptides and
biomolecules. 174
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QDs were conjugated with DNA molecules and QD:DNA arrays were generated
which self-assemble spontaneously. 177. 178 Pathak et al. used QDs to detect the
hybridization of DNA to complimentary sequences. 179 In this study, QDs were
conjugated with two separate oligonucleotides, one having a known complimentary
sequence present only in human Y chromosome and another random sequence with no
known complimentary sequence. When these QDs:DNA conjugates were incubated with
human sperm cells, strong fluorescence signal was observed in the cells with Y
chromosome indicating successful hybridization of the DNA. However, minimal or no
signal was observed with the one labeled with random sequence indicating low
nonspecific hybridization. QDs conjugated to IgG and streptavidin were used to label
breast cancer marker, Her2, on the surface of cancer cells. Other cellular targets like actin
and microtubule fibers in the cytoplasm, nuclear antigens were also labeled using specific
QDs bioconjugates. 167
QDs were also used to track motility and migration of cells. Cancer cells uptake
QDs and leave behind a fluorescence free phagokinetic tail during their migration. 18o The
photobleaching resistance property of QDs was exploited by Dahan et aI., in which
individual glycine receptors in neuronal cells were tracked using single QDS. 181 Micelle
stabilized QDs were used as cell lineage tracers by injecting into Xenopus embryos.166 In
this study, it was demonstrated that the QDs are stable in vivo and non-toxic and their
strong fluorescence could be followed to the tadpole stage. The large stokes shift in the
QDs was mainly exploited in many in vivo applications as it overcomes the problems of
auto fluorescence from the tissue. Near infrared QDs with emission

~

840nm were

synthesized which achieved deeper penetration than the currently available near infrared
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dyes. 182, 183 Kim et al. demonstrated the use of the near infrared QDs in bioimaging by
applying them to sentinel lymph node-mapping in cancer surgery of large animals. 184
QDs were also used for tracking of tumor cells in vivo during metastasis by conjugating
to tumor targeting antibodies. 169, 185 In vivo studies performed in mice with human cancer
cells showed that the QDs conjugates accumulate at the tumor sites when tracked using
multiphoton microscopy. Thus QDs provide the ability for cell tracking in vivo without
compromising or sacrificing the animals which is an enormous improvement in
comparison to current techniques. Bioconjugated QDs were also used for assays like
micro-nanaoarrays, FRET and ELISA for the detection of specific clinical markers.186.188
5.54 Toxicity of QDs

Most of the commonly used QDs are made of toxic heavy metal atoms like Cd,
Hg, Pb, As and the like. CdSe QDs contains the divalent cadmium which is a nephrotoxin
in its ionic form. Even though they are embedded in a biological unreactive ZnS shell and
a polymer coating, the toxicity of these QDs is not very well understood. As the toxicity
due to Cd+2 is well reported, large amount of research was focused on the release of free
cadmium ions into the cells. Cadmium ions released can bind to sulfhydryl groups
present in many biomolecules like proteins which causes decrease in the functionality of
various subcellular organelles. Yang et al. assessed the tissue disposition and
pharmacokinetics of QDs in mice after a single intravenous injection for up to 28 days by
measuring the cadmium levels using inductively coupled plasma-mass spectrometry
(lCP-MS).189 Increased levels of cadmium were observed in the liver and kidneys
indicating the degradation of QDs over time. However, it was not apparent whether the
cadmium is in free form or in nanocrystalline form. Several other groups have
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investigated the release of Cd+2 and have observed that its release correlates with the
cytotoxic indications. 190, 191 When CdSe QDs were exposed to air or UV light, oxidative
release of Cd+2 was observed. However, coating these QDs with ZnS shells virtually
minimized the toxicity indicating that the shell protects the release of the cadmium. 192
More recently, greener chemistry based and non-cadmium based QDs were synthesized
for reduced toxicity in biomedical applications. 193,

194

Despite several studies, it is

difficult to conclude about the toxicity due to the variation in the synthesis, surface
coatings of the QDs and the experimental conditions like the cells under investigation,
time of exposure and concentrations used.
5.6 ODs IN THIS DISSERTATION

In this dissertation, QDs are used for cellular labeling and imaging of
biomolecules. Commercially available CdSe/ZnS core/shell QDs are purchased from
Ocean Nanotech, LLC. They have fluorescence emission

~

530 nm, hydrodynamic size

of ~ 26±6.07 nm and a zeta potential around - 43.05mV. As purchased QDs are coated
with amphiphilic polymer and are dispersed in aqueous borate buffer solutions with
reactive carboxyl groups. The organic layers consist of a monolayer of oleic
acidloctadecylamine and a monolayer of amphiphilic polymer with the thickness of the
total organic layers ~4 nm.
The ability to image QDs in cells for extended periods of time helps in studying
living cells and tissue in real time. The motivation for the use of QDs in this dissertation
is to study the activity of an important intracellular protein- NF-kB (Nuclear Factor
kappa-light chain-enhancer of activated B cells). NF-kB consists of family of proteins

99

that play an important role in many biological processes such as inducing immune and
inflammatory responses, developmental processes, cellular growth and cell death or
apoptosis. Traditionally, the activity of this particular protein is assessed by performing
assays like immunofluorescence using fluorescent labeled antibodies. However, this
approach has a number of disadvantages. Firstly, the antibodies are fluorescently labeled
using organic dyes like FITC or Texas Red which photobleach very quickly and have low
signal-to-noise ratio over time. The assays performed require the cells to be fixed to study
the activity of the protein at a particular time point. QDs not only provide strong
fluorescence with high signal-to-noise ratio but also significantly improve the real-time
detection of the protein.
The use of QDs in this dissertation is divided into two sections. In the first
section, novel technique for the intracellular delivery of QDs is demonstrated. In the next
section, QDs are conjugated to antibodies of the NF -kB protein and preliminary results
showing the ability of antibody conjugated QDs to label the protein is presented.
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CHAPTER VI - REVERSIBLE PERMEABILIZATION FOR
INTRACELLULAR DELIVERY OF QDs

6.1 PURPOSE OF THE STUDY

The motivation for the use of QDs in this dissertation is to utilize their unique
ability to image intracellular biomolecules like proteins over extended periods of time. In
this dissertation, QDs are conjugated to antibody specific to an important functional
protein- NF-kB (Nuclear Factor kappa-light chain-enhancer of activated B cells). It is a
nuclear transcriptional factor consisting of 5 subunits- p65/ReIA, p50/p105, p52/plOO,
RelB, and c-Rel, that form homo- or heterodimers.19S-197 The classic form of NF-kB
family is the heterodimer of the p65 and p50 subunits. NF-kB plays an important role in
many biological processes like inducing immune and inflammatory responses, cell
developmental processes, cellular growth and cell death or apoptosis. 198
In unstimulated cells NF -kB dimers (p65/p50) are sequestered in the cytosol as
they are bound to an inhibitory complex, IkB. The IkB inhibitory protein masks the
recognition of the nuclear localization signal (NLS) present within the NF-kB sequence
and thus restricts the NF-kB in the cytoplasm. Upon cell stimulation, IkB kinase (lKK)
complex gets activated that leads to the phosphorylation and ubiquitination of IkB. This
degradation of IkB allows the release of NFkB which is free to translocate into the
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nucleus. In the nucleus, NF-kB binds to specific DNA elements and activates the
transcription of genes. NF-kB activates to various external stimuli including bacterial
products, viruses, stress (oxidative, physiological or physical), inflammatory cytokines
and environmental hazards such as radiation. 199-201 (Figure 6.1) It is also reported that
abnormal and constitutive activation of NF-kB is associated with many chronic human
diseases including arthritis, asthma, cancer, diabetes, stroke and AIDS. 202 , 203 Thus
inhibition of NF-kB activation is an emerging theme in the design of anti-inflammation
therapies as it is clinically relevant for the treatment of diseases that involve
inflammation.204-206 Several studies reported that the pathophysiological role of NF-kB
can be either protective or detrimental and significance of the type of cells is also not
very well understood. Hamid et al investigated the role of NF-kB in heart failure and
demonstrated that chronic activation of NF-kB p65 in myocytes exacerbates cardiac
remodeling and is pro-apoptotic. 207 The presence ofNF-kB p65 and p50 is studied using
techniques like immunohistochemistry, ELISA and western blots which involve fixing
the cells at particular time point. However, these techniques are not only laborious but
also time consuming. QDs are excellent candidates to observe the dynamics of the
activity ofNF-kB in real time in live cells.
In this dissertation, QDs are conjugated with antibodies specific to NF-kB p65
subunit and their bright fluorescence will be used to image the nuclear translocation of
NF-kB upon cell stimulation.

H9c2 cells, rat cardiomyocyte cell line, are used as

representative model to test the nuclear translocation ofNF-kB p65.
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Figure 6.1 Schematic showing the activity of NF-kB. (A) In unstimulated cell NF-kB is
inactive as it is bound to inhibitory protein IkB, (B) whereas in stimulated cell,
proinfiammatory stimuli activates specific protein kinase resulting in the degradation of
IkB and nuclear translocation ofNF-kB?04

H9c2 cells are stimulated with different external stimuli like TNF-a (tumor
necrosis factor), UV radiation and bacterial LPS (lipopolysaccharide) and QDs: p65 NFkB conjugates are used to detect the presence of NF-kB protein. The bioconjugation of
QDs with NF-kB p65 antibodies and the experimental conditions are discussed in detail
in the subsequent sections.
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6.2 INTRACELLULAR DELIVERY OF QDS
Prior to imaging nuclear translocation ofNF-kB using QDs, intracellular delivery
of freely dispersed QDs: NF-kB conjugates needs to be accomplished. Traditional
bimolecular delivery methods utilize plasmids, cationic polymers, lipids, and viruses
which have inherent disadvantages such as degradation in physiological solutions and
need for complex conjugation techniques. 208 ,209,210 QDs have high chemical and
biochemical stability and their small size and large surface area allows simultaneous
conjugation with multiple biomolecules making them highly desirable as imaging agents
and biomolecular delivery vehicles for biomedical applications. 16o Typically, the QDs
were dispersed in aqueous buffer solutions and have been successfully functionalized
with various biomolecules like DNA, proteins and antibodies for delivery applications. 159
This chapter reviews the current methods for the intracellular delivery of QDs. A novel
technique for efficient intracellular delivery of QDs will be discussed along with
experimental materials and methods. The preparation of QDs: NF-kB p65 conjugates
along with stimulation of cells for nuclear translocation ofNF-kB is also discussed.
6.2.1 Current intracellular delivery methods
A major challenge is the efficient intracellular delivery of monodispersed QDsbioconjugates freely dispersed in the cytoplasm. Intracellular delivery methods for QDs
are classified into nonspecific and targeted intracellular delivery. Several methods have
been developed for the delivery of QDs into cells including both biochemical methods
such as endocytosis, pinocytosis, lipids and physical methods such as electroporation and
micro/nanoinjection. 211 A schematic of various methods and techniques for intracellular
delivery of QDs is shown in Figure 6.2

104

Pore-Forming Toxins

..

Electroporation

Cytoplasm

St ep 2: Hypotonic medium

~

\.';:J
Chemical Transfection

Step 1: Hypertonic medium

Osmotic Pinosome Lysis

Figure 6.2 Schematic of different methods and techniques for intracellular delivery of
QDs (shown in red).)73
One of the most common methods for the uptake of QDs or any extracellular
material, by the mammalian cells is through cell mediated methods like phagocytosis,
clathrin-dependent endocytosis, macropinocytosis, caveolae-dependent endocytosis.
Endocytic pathways are typically used by pathogens like viruses, bacteria and other
microorganisms to gain entry into cells. Some of these pathways are also applicable for
the uptake of QDs by the cells. Phagocytosis is less relevant in the intracellular delivery
of QDs as it usually involves uptake of foreign pathogens like viruses or bacteria by
specialized cells known as phagocytes. Clathrin-dependent endocytosis is most common
for a large number of cells and is also well understood method of endocytosis which is
mediated by the large protein clathrin. In this method, biomolecules and nanoparticles
like QDs initially attach to the receptors or proteins present on the cell membrane and the
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protein (clathrin) assists in the formation of a coated pit on the inner surface of the
plasma membrane of the cell. The clathrin coated pits are

~

150 nanometer invaginated

structures on the plasma membrane which occupy 2% of the plasma membrane surface.
In doing so, it brings a small volume of extracellular fluid from outside to inside of the
cell. Biju et al. investigated the use of this method for the delivery of QDs: peptide
conjugates into live cells. 212 Interestingly, it was observed that the intracellular delivery
of QDs conjugates was reduced by ~ 57% when the formation of clathrin coated pits was
blocked. In this study, it was shown that though multiple pathways are involved in the
intracellular delivery of conjugates, clathrin dependent endocytosis was the most
important. Caveolae -dependent endocytosis involves the formation of non-clathrin
coated pits formed from the plasma membrane which is more common for smooth
muscle cells, fibroblasts and endothelial cells. In this method of endocytosis,
biomolecules and nanoparticles like QDs were trapped in small flask shaped pits called
caveolae, resembling like caves

~50

nanometers in size. Caveloin, a transmembrane

protein assists in the formation of pits enriched in proteins, cholesterol and glycolipids.
Both the clathrin-dependent and the caveolae-dependent endocytosis methods can be
either non-specific or receptor mediated pathways.
Other non-specific methods of endocytosis for intracellular delivery of QDs are
macropinocytosis, lipids/liposomes and polymers. Macropinocytosis, discovered by
Warren Lewis in 1931 is a form of endocytosis which involves ruffling of the cell
surface. 213 The formation of relatively large macropinosomes provides a good route for
non-selective endocytosis of macromolecules. Okada et al. demonstrated the introduction
of macromolecules into mammalian using osmotic lysis of pinocytic vesicles. 214 In this
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method, cells were first incubated in hypertonic culture medium containing sucrose,
polyethylene glycol and the macromolecule to be loaded. This results in rapid formation
of pinocytic vesicles formed of the plasma membrane due to movement of water out of
the cells. In the next step, pinocytic vesicles containing the macromolecule to be
delivered were burst by placing the cells briefly in hypotonic medium (medium diluted
with DI water) which creates an internal osmotic pressure. This releases the contents in
the vesicles filling the cytosol with the macromolecule. Courty et al. demonstrated the
delivery of QDs conjugates into live cells using macropinocytosis to detect intracellular
movement of single molecular motors. 215
Surface charge and hydrophobicity are the two major factors in the endocytosis of
QDs using cationic lipids and polymers. Cationic lipds/liposomes were also extensively
used for the intracellular delivery of QDs due to their underlying advantages such as wide
availability, biocompatibility and cost effectiveness. Derfus et al. demonstrated that the
QDs complexed within transfection agents such as cationic liposomes derived from
lipofectamine 2000 were endocytosed by the cells. 216 QDs coated with polymers were
shown to undergo nonspecific endocytosis. 217 , 218 Pore forming bacterial toxins like
streptolysin 0 which temporarily permeabilizes the plasma membrane were also
investigated for the delivery of QDS. 173 However, the activity of streptolysis 0 wass not
stable and was difficult to control.
The above methods though successful in the QDs delivery into the cellular
cytoplasm, the QDs delivered were aggregates, limiting their utility.159,219 Endocytosis
delivered QDs were trapped in the vesicles preventing the labeling of other intracellular
components such as mitochondria or nucleus. Delivery of QDs as aggregates restricts
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their subsequent trafficking such as translocation to nucleus. Moreover, the biomolecule
or antibody (to be delivered) attached to the QDs will remain trapped in the vesicles
making it unavailable for subsequent molecular recognition. Aggregation of QDs can
affect their stability as well as may result in the quenching of the fluorescence emission.
More recently, chemical transfection methods like endosome-disrupting (endosomolytic)
surface coatings were employed for intracellular delivery of QDs. 220 The QDs were
coated with copolymer ligands such as polyethylene glycol grafted polyethylenimine
(PEI-g-PEG) and were rapidly internalized by the cells and released into the cytoplasm
by slow endosomal escape. The presences of amine groups on each PEl molecule not
only help in rapid endocytosis of across cell membranes but also in disruption of
intracellular organelles though proton sponge effect. Kim et al. encapsulated antibody
coated QDs within biodegradable polymeric nanospheres and the intracellular delivery
was based on the hydrolysis of the polymeric spheres once inside the cells. 221 Though
these methods help in the delivery of QDs into the cytosol; the delivery is not
homogenous. Moreover, the mechanism of the release of the QDs from the endosomes is
not well understood. Peptide conjugated QDs were also investigated for the efficient
intracellular delivery. The most commonly used peptide is Tat peptide (trans-activating
transcriptional activator) which was readily uptaken by many cell types due to its net
positive charge. Ruan et al. demonstrated that the QDs conjugated with Tat peptides
attach to the negatively charged cell membranes through electrostatic interactions and
internalized through macropinocytosis. 222

108

Physical methods like electroporation were also utilized to deliver large quantities
of QDs into cells. 216 An electric pulse charges the cell membranes resulting in the
rearrangement of lipid molecules. This creates small hydrophilic pores in the cell
membrane through which foreign particles and extracellular fluid can enter the
cytoplasm. Even though large numbers of QDs were delivered using this technique, the
delivery is not homogenous and the electrical pulses may result in high cell mortality.223
The only technique that has been shown to accomplish homogenous distribution of QDs
into the cytosol or nucleus without endosomal trapping is microinjection?16,166 In this
technique, a small amount (typically few femtoliters) of QDs were introduced into the
cells using a very fine capillary or a needle using a fluorescent microscope to guide the
targeting of the cells. Dubertret et al. microinjected CdSe/ZnS QDs encapsulated in
phospholipid micelles into Xenopus embryonic cells for in vivo imaging. 166
Microinjection was also used for delivery of QDs for intracellular labeling of specific
organelles such as selective labeling of nucleus and mitochondria216 Chen et al.
developed a nanoinjector made of carbon nanotubes and demonstrated delivery of protein
conjugated QDs into live human cells. 224 The major disadvantages of microinjection
technique are that it is highly operator dependent, laborious and low throughput process
accomplished by injecting one or few cells at a time. 216,166 The efficiency of
microinjection is also dependent on physical constraints like cell morphology, membrane
thickness and cell height. Further, the equipment needed to perform microinjection is
usually very expensive relative to other techniques. Therefore, a more efficient method to
accomplish freely diffused QDs inside live cells is needed for labeling of cellular
components as well as intracellular delivery ofbiomolecules.

109

6.2.2 Reversible permeabilization of live cells

A major barrier for the entry of extracellular molecules into cell interior is the
plasma membrane. Selective and reversible permeabilization of the plasma membrane is
necessary for intracellular delivery of biomolecules and nanoparticles. Permeability of
the plasma membrane to various biomolecules is related to the structure of the
hydrophilic lipid bilayer exposed to the aqueous environment and the fatty acyl chains
that form the hydrophobic core. Permeabilization of plasma membrane involves the
formation of transient defects and passage of the permeant molecules across the
membrane through these defects.

Permeability is also dependent on the physical

properties, composition and the homogeneity of the membrane as well as the polarity and
size of the permeant molecule. For successful intracellular delivery, permeabilization
method should satisfy two important criteria. Firstly, it should be selective to the specific
target membrane without compromising other areas of the cell. For example, some
applications require permeabilization of only plasma membrane without affecting other
intracellular organelles like mitochondria or nucleus. Secondly and most importantly, the
permeabilization should be reversible especially for applications which require long term
viability of the cells. 225
Chemical detergents like Triton X-100, Saponin and digitonin are the commonly
used cell permeabilization agents for intracellular delivery of biomolecules like
antibodies

and

fluorescent

proteins.

However,

they

were

largely

used

III

immunohistochemistry applications involving fixed/dead cells and tissues. Triton-X was
successfully used to reversibly permeabilize live cells for delivery of optical contrast
agents ranging from lkDa to 150kDa in molecular weight. 226 It was reported that
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treatment of cells with near mInImUm concentrations of Triton-X, membrane
permeabilization was reversible and its integrity was typically restored after 24 hours.
However, Triton X-lOa has relatively lower selectivity in applications which require
selective permeabilization of cytoplasm leaving the nucleus intact. It was also reported
that use of Triton x-loa may cause loss of detection of some membrane proteins. 227 A
non-ionic detergent, digitonin was used to induce reversible permeabilization of plasma
membrane in cells. 228 Treatment of cells with low concentrations of digitonin was shown
to selectively permeabilize the plasma membrane due to its high cholesterol content. The
nuclear envelope was left intact and the cytoskeleton was largely undisturbed.229, 230 The
mechanism in which the membrane reseals following the treatment with digitonin is not
well understood. However, it was largely attributed to the presence ofCa+2.231 Lowe et al.
investigated the selectivity of nuclear pore complex in digitonin pemeabilized cells using
protein conjugated QDS. 232
Saponin, another cell permeabilization agent, is a plant derived glycoside known
for its foaming and hemolytic activity.233 The membrane solubilizing effect of Saponin is
mainly attributed to its ability to form complexes with cholesterol. A mixture of Saponin
and cholesterol results in the formation hexagonal rings of diameters

~

8 nanometers with

the Saponin carbohydrate domains at the center without any membrane discontinuities. 234 ,
235 Scanning electron microscopy revealed that Saponin creates holes in the cell surface
membrane in the size ranges from 100 nanometers to I micrometer. 236 Wassler el al.
demonstrated the use of different concentrations of Saponin to accomplish differential
permeabilization of membranes. 237 Saponin was also used for permeabilization of cells as
well as for the introduction of macromolecules like trypan blue and exogenous tRNA. 238
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It was reported that when cells were treated with Saponin, there was minimal release of

the intracellular macromolecules with minimal damage to the internal architecture and
the protein synthesis remained at comparable levels with that of intact cells. 239 Moreover,
treated cells allowed the entry of molecules of at least 800kDa. Johnson et al.
demonstrated reversible permeabilization of neonatal cardiac myocytes using Saponin
and accomplished the delivery of peptides into cells. 240
In this dissertation, a new technique for homogenous and endocytosis free
delivery of QDs using reversible permeabilization of live cells will be presented. This is
acheved using low concentrations of Saponin in the presence of hypotonic environment.
To minimize the effect of endocytic internalization pathway of QDs, experiments were
performed at 4°C to minimize the energy available for endocytosis.241 Saponin
permeabilization however allows bidirectional transport (i.e.) into and out of the cell
which can compromise cellular processes via loss of vital intracellular molecular
contents. To ensure unidirectional transport into the cell, Saponin is used in combination
with hypotonic exposure to enhance osmosis driven transport of QDs into the cell while
minimizing leakage of intracellular contents out of the cell. Hypotonic exposure causes
an influx of fluid into the cell due to the osmotic pressure gradient which can be exploited
to transport QDs along with the fluid into the cytoplasm of the cell. Several studies have
demonstrated that the osmosis based methods can be used to transport fluids 242 ,243,244 and
. .m com b"mation WIt. h h ypotomc
.
·
other macromo1ecu1es mto
ce11 s. 214 ' 245 ,246 Saponm
conditions was found to be extremely efficient in accomplishing endocytosis-free
delivery of QDs into the cellular cytoplasm while maintaining cell viability. Further, the
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QDs delivered were vesicle-free and were well dispersed within the cell for imaging and
biomolecular delivery applications.
6.3 EXPERIMENTAL MATERIALS AND METHODS
6.3.1 Materials

Water soluble CdSe/ZnS core/shell QDs with emission

~530nm,

hydrodynamic

size of 26±6.07 nanometers and zeta potential of -43.05mV are used which are purchased
from Ocean Nanotech, LLC (Springdale, AR). The NF-kB p65 antibodies (SC-8008)
without gelatin are obtained from Santa Cruz biotechnology (Santa Cruz, CA). Custom
conjugation of QDs (em

~530)

with NF-kB p65 antibodies is obtained from Ocean

Nanotech, LLC and is also performed using Qdot 605 antibody conjugation kit
(Invitrogen). Saponin for reversible permeabilization experiments is purchased from Alfa
Aesar (Ward Hill, MA) and deionized water (DI) for the hypotonic experiments is
obtained for Milli-Q filtration system purchased from Millipore (Billerica, MA). Cell
stimulation is performed using bacterial LPS (Sigma Aldrich, St. Louis, MO), TNF-a
(BD biosciences, San Jose, CA) and UV lamp (in laboratory cell culture hood).
Paraformaldehyde used for fixing of the cells, Triton X-I 00 used for permeabilization,
BSA (bovine serum albumin) used to block non-specific binding are obtained from
Sigma Aldrich(St. Louis, MO). All other reagents like PBS, Tween-20,sucrose,
potassium chloride, potassium acetate and HEPES are obtained from Sigma Aldrich. (St.
Louis, MO)
6.3.2 Cell culture

All experiments utilized a rat cardiomyocyte cell line; H9c2 cells (American Type
Culture Collection). The H9c2 cells are cultured in Dulbecco's Modification of Eagle's
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Medium (DMEM) with 4.5 gIL glucose, L-glutamine, and sodium pyruvate (Fischer
Scientific), 10% fetal bovine serum (FBS, Hyclone) and 1% antibiotics (penicillin and
streptomycin, Mediatech). Cells ae cultured in LabTek chambered cover glass (Fischer
Scientific) and in multi-well plates (BD falcon) at a density of approximately 1.2 x 104
cells/cm2 . Trypsin EDTA (Mediatech) is used to detach the cells from the surface for
flow cytometry (BD FACS calibur) studies.
6.3.3 Blocking of endocytosis at 4°C
Mammalian cells when exposed to QDs at room temperature readily internalize
QDs through energy dependent endocytosis. 219 H9c2 cells are used as representative
mammalian cell line to evaluate their response to QDs delivered at both room
temperature and 4°C. Cells seeded are treated with QDs (~10nM) for 10 minutes at room
temperature as well as at 4°C in serum free media. Cells alone without QDs are used as
negative control. After the incubation, cells are washed with 1x PBS and media and
observed under a confocal microscope (Nikon A 1 confocal system). In order to evaluate
the efficacy of the reversible permeabilization technique as well as ensure endocytosisfree intracellular delivery of QDs, all the experiments were performed at 4°C.
6.3.4 Reversible permeabilization using hypotonic buffer
H9c2 cells are seeded at a density of approximately 1.2 x 104 cells/cm2 • After 24
hours, the media is removed and washed twice with 1x PBS for cell internalization
studies. Hypotonic buffer solutions at three different ratios (l :1, 3:2, 1:3) are prepared by
mixing S buffer239 (130 mM sucrose, 50 mM KCI, 50 mM potassium acetate, 20 mM
HEPES, pH 7.4) with DI water at respective ratios. Cells are treated with QDs

(~lOnM)

mixed in the three hypotonic solutions at a pH around 7.4 for 2 minutes, 5 minutes and 10
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minutes at 4°C on a rotary shaker. After each time point, the cells are washed twice with
the respective hypotonic buffer solutions, once with Ix PBS and thoroughly washed with
regular media. Cells are then incubated at 37°C for 30-45min for recovery before imaging
using confocal microscopy.
6.3.5 Reversible permeabilization using Saponin

Saponin solutions are prepared at three different concentrations 25Ilg/ml, 50llg/ml
and 751lg/ml in hypotonic buffer (3:2 ratio of buffer to DI water). Cells are treated with
QDs

(~1 OnM)

mixed with the above hypotonic Saponin solutions for 2 minutes, 5

minutes and 10 minutes at 4°C on a rotary shaker. After each time point, the cells are
washed twice with hypotonic S buffer (3:2 ratio) solution, once with Ix PBS and
thoroughly washed with regular media and incubated for 30-45 minutes at 37°C for
recovery. Control experiments are done by treating cells with and without QDs

(~10nM)

in 1x PBS for 10 minutes and without Saponin or hypotonic conditions. Cell
permeabilization and internalization of QDs is confirmed by imaging live cells using
confocal microscopy.
6.3.6 Evaluation of cell viability

Following hypotonic and Saponin treatments, reversible permeabilization is
confirmed by evaluating cell viability using the live/dead viability/cytotoxicity kit
(Invitrogen). Cells are cultured in multi-well plate and the viability study is done
following the instructions in the kit. Briefly, 6111 of Calcein AM and 15111 of Ethidium
homodimer are mixed well in 12 ml of Ix PBS for 15 minutes. After the recovery of the
cells for 30-45 minutes following hypotonic and Saponin treatments, cells are treated
with 400111 of the prepared calcein-ethidium homodimer solution and incubated at 37°C
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for 30-45 minutes. Positive and negative control experiments are cells treated with
Saponin without hypotonic conditions and cells without Saponin or hypotonic buffer
respectively. The cells are then carefully washed with lx PBS and imaged under a
fluorescent microscope (Nikon eclipse TE 2000-U). Live cells are distinguished by the
presence of ubiquitous intracellular esterase activity, determined by the enzymatic
conversion of the virtually non-fluorescent cell-permeant calcein AM to the intensely
fluorescent calcein. The polyanionic dye calcein is well retained within live cells and
produces an intense uniform green fluorescence (ex/em

~495nm/~515nm)

in live cells.

EthD-l enters cells with damaged membranes and undergoes a 40-fold enhancement of
fluorescence upon binding to nucleic acids, thereby producing a bright red fluorescence
(ex/em

~495nm1~635nm)

in dead cells. EthD-l is excluded by the intact plasma

membrane of live cells. The cell viability assay is performed without the QDs due to the
overlapping of their emission with the calcein dye used.
6.3.7 Significance of hypotonic buffer conditions

The significance of hypotonic buffer environment is evaluated by treating H9c2
cells with Saponin in the absence of the hypotonic buffer conditions. The chosen
concentration of Saponin for this study is 125 Ilg/ml. This concentration is higher than
the concentrations used for the study with hypotonic buffer (25-75 Ilg/ml), however, in
the absence of hypotonic buffer the lower concentrations of Saponin resulted in poor
intracellular QD delivery. The 125 Ilg/ml is the lowest concentration of Saponin at which
appreciable uptake of QDs in the cells is observed. Cells treated with Img/ml of and 0
mg/ml of Saponin for 10 minutes are used as positive and negative controls respectively.

116

Following the treatment, cells are recovered at 37°C for 30-45 minutes and cell viability
is evaluated using live/dead assay.
6.3.8 Quantitative and qualitative analysis using fluorescence microscopy

All images for the hypotonic and Saponin experiments are obtained using Nikon
Al confocal fluorescent microscope using of 60x magnification. The brightness and
contrast are equally readjusted for all the images in Adobe Photoshop. All the images for
the cell viability assay are obtained using Nikon eclipse TE 2000-U fluorescent
microscope. The percentage of live and dead cells are obtained from the fluorescent
images by counting the number of cells showing green (live) and red (dead) fluorescence
using metamorph software.
6.3.9 Quantitative analysis using flow cytometry

The mean fluorescence intensity (MFI) or the G mean of the cell internalized QDs
is assessed using flow cytometry. Following the hypotonic and Saponin treatments of
cells with QDs, cells are detached from the plate using Trypsin-EDTA and suspended in
flow buffer for flow cytometry. Cells are visualized by the strong green

(~530nm)

fluorescence from the QDs using the signal from the FLI band pass emission (530±30)
filter. The population histograms showing the fluorescence intensity of QDs from the
cells is generated using Cell Quest Pro software.
6.4. QDS: NF -KB P65 ANTIBODY CONJUGATES

QDs are conjugated with NF -kB p65 antibodies usmg standard conjugation
methods. Carboxyl terminated QDs (em

~

530nm and

~600nm)

are activated using

EDAC and then either directly conjugated to the amino groups present on the NF-kB p65
antibodies or via a fusion protein, protein G (pG). Custom conjugation of NF-kB p65
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antibodies with QDs is obtained from Ocean Nanotech LLC. The conjugation of QDs
with the antibodies is confirmed using gel electrophoresis. QDs (em

~605nm)

are also

conjugated with NF-kB p65 antibodies using commercially available conjugation kit
(Invitrogen). Briefly, the QDs are amine derivatized and coated with PEG groups. The
conjugation of the QDs with the NF-kB p65 antibodies is performed by first activating
the QDs using SMCC to generate reactive maleimides groups. Following this step, the
activated QDs are coupled to the antibodies by coupling the reactive maleimides groups
to the thiol groups present in the NF-kB p65 antibodies. In this dissertation, QDs with
emission

~

530 nm are used for intracellular delivery study while QDs with emission

~

530nm and ~ 600nm are used for labeling ofNF-kB protein study.
6.4.1 Stimulation of cells for activation of NF-kB

H9c2 cells are cultured in regular media LabTek chambered cover glass at a
density of approximately 1.2 x 104 cells/cm2 . The seeded cells are starved in media
without serum and antibiotics overnight prior to stimulation. Cells are then stimulated for
the activation and nuclear translocation of NF-kB with LPS, TNF-a and UV radiation.
Serum starved cells are stimulated with LPS at a concentration of ~ 100 Ilg/ml for 2 hours
and with TNF-a at a concentration of

~

50ng/ml for 1 hour to at 37°C. Cells are

stimulated with UV radiation using the standard UV lamp in cell culture hood for 2 hours
at room temperature.
6.4.2 Immunofluorescence microscopy

Following the cells stimulation, the activation and nuclear translocation ofNF-kB,
IS

detected using the QDs fluorescence by performing standard immunofluorescence

microscopy. Briefly, after the stimulation, cells are fixed using 2% paraformaldehyde for
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20 minutes at 37°C. Cells are washed with Ix PBS twice and permeabilized using 0.1%
Triton X-IOO for 5 minutes at room temperature. After the permeabilization, cells are
washed twice with wash buffer (0.05% Tween-20 in Ix PBS). Non-specific binding is
blocked by incubating the cells with 0.5-1% BSA in Ix PBS for 30 minutes at room
temperature. QDs: NF-kB p65 conjugates (- IOnM concentration) are added to the cells
and allowed to incubate for 1 hour at room temperature on a rotary shaker. Following the
incubation with the QDs conjugated antibodies; cells are thoroughly washed three times
with wash buffer for 5 minutes. The successful labeling the NF-kB protein using the
QDs: NF-kB p65 conjugates is confirmed by imaging the cells using confocal
microscopy.

119

CHAPTER VII -RESULTS AND DISCUSSION

This chapter deals with the results obtained in the intracellular delivery of QDs
using the reversible permeabilization method. The discussion section deals with
interpretation of the observed results. The preliminary results showing the conjugation of
QDs with NF-kB p65 antibodies and ability of QDs to image the nuclear translocation of
NF-kB upon cell stimulation are presented at the end of the chapter.
7.1 RESULTS

This section deals with the results from the reversible permeabilization
experiments for the intracellular delivery of QDs.
7. 1.1 Endocytosis blocked at 4°C

Several studies have indicated that mammalian cells exposed to nanomaterials
like carbon nanotubes and QDs at room temperature readily internalized them via
endocytic pathways whereas exposure at 4°C inhibited endocytosis. 247 ,219 Using H9c2
cells as a representative mammalian cell line, the uptake of QDs delivered at both room
temperature and 4°C is evaluated. It is observed that the QDs are internalized by the cells
when they are incubated at room temperature via energy dependent endocytic pathway
for the uptake of QDs. The uptaken QDs are seen as aggregates as evident from the
punctuate

fluorescence

typically

seen
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In

endocytic

uptake

mechanism.

(Figure 7.1). However, minimal uptake is observed when the cells are incubated with
QDs at 4°C (Figure 7.2). This shows that the endocytic pathways can be blocked by
incubating the QDs at low temperature. Minimal or low auto fluorescence is observed in
the cells incubated without the QDs (negative control) as shown in Figure 7.3.

Figure 7.1. Confocal image of H9c2 cells showing endocytosis like uptake of QDs (A)
Phase contrast, (B) Fluorescence images of cells incubated at room temperature (RT)
with QDs. The punctuate fluorescence is indicative of endocytic uptake pathway. The
images are taken with 60x magnification.

In order to test the efficiency of the reversible penneabilization method and to

ensure endocytosis-free delivery, all the QDs internalization experiments are perfonned
at 4°C. Therefore, the results obtained can be interpreted based only on the reversible
penneabilization mechanism eliminating the endocytic pathways.
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Figure 7.2. Confocal image of H9c2 cells showing blocking of endocytosis of QDs (A)
Phase contrast, (B) Fluorescence images of cells incubated at 4°C with QDs. Minimal or
very low fluorescence is observed indicating the successful blocking of endocytosis. The
images are taken with 60x magnification.
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Figure 7.3 . Confocal image of H9c2 cells without QDs as negative control (A) Phase
contrast, (B) Fluorescence images of cells incubated without QDs. Minimal or very low
auto fluorescence from the cells is observed.
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7.1.2 Reversible permeabilization using hypotonic buffer

This section deals with the results obtained from the reversible permeabilization
experiments for the intracellular delivery of QDs using hypotonic buffer conditions. H9c2
cells cultured for 24 hours are treated with QDs (-1OnM) mixed in different hypotonic
buffer ratio conditions (1:1 , 3:2, 1:3) for 2 minutes, 5 minutes and 10 minutes. As the
experiments are performed at 4°C, the uptake of QDs occurred largely due to osmotic
loading method. Live cell confocal microscopy is performed to confirm the internalization
and distribution of the QDs in the cells. Confocal phase contrast and fluorescence images
of cells internalized QDs when treated with 1:1 (Figure 7.4), 3:2 (Figure 7.5) and 1:3
(Figure 7.6) buffer: DI water ratios for 2 minutes (A, B), 5 minutes (D, E) and 10 minutes
(G, H) respectively are shown. It is observed that the QDs internalized are well distributed
as seen from the fluorescence signal from the cytoplasm of the cells (Figures 7.4, 7.5 and
7.6). Furthermore, when the cells are treated with 3:2 buffer: DI water hypotonic ratio for
5 minutes (Figure 7.5 D, E), the internalized QDs are homogenously distributed in the
cytoplasm as seen from the diffused fluorescence signal.
Cell viability following the hypotonic treatments is analyzed from live/dead
assay. Representative cell viability fluorescence images shown in the panels C, F and I
(Figures 7.4, 7.5 and 7.6) show fluorescence overlay of ca1cein AM (green: live cells) and
ethidium homodimer-l (red: cells with damaged cell membrane) for the three different
hypotonic buffers ratios (l: 1, 3 :2, 1:3) for the different times (2 minutes, 5 minutes, 10
minutes) respectively. High number of live cells and minimal or low number of dead cells
is observed as evident from high green and minimal red fluorescence signal as a
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consequence of exposure to the different hypotonic buffer ratios. However, swelling of the
cells is observed when higher hypotonic ratios and with longer incubation times.
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Figure 7.4. Reversible permeabilization using 1: 1 hypotonic buffer ratio and cell viability.
Comparison of bright field, fluorescence and viability representative images of H9c2 cells
treated with 1: 1 hypotonic buffer ratio for uptake of QDs for (A-C) 2 minutes, (D-F) 5
minutes and (G-I) 10 minutes respectively at 4°C. Bright field and fluorescence images are
obtained with 60x magnification and cell viability images are obtained with lOx
magnification. Cell viability fluorescence images (C, F and J) show fluorescence overlay
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of calcein AM (green: live cells) and ethidium homodimer- l (red: cells with damaged cell
membrane).
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Figure 7.5 Reversible permeabilization using 3:2 hypotonic buffer ratio and cell viability.
Comparison of bright field, fluorescence and viability representative images of H9c2 cells
treated with 1: 1 hypotonic buffer ratio for uptake of QDs for (A-C) 2 minutes, (D-F) 5
minutes and (G-I) 10 minutes respectively at 4°C. Bright field and fluorescence images are
obtained with 60 x magnification and cell viability images are obtained with lO x
magnification. Cell viability fluorescence images (C, F and I) show fluorescence overlay
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of calcein AM (green: live cells) and ethidium homodimer-l (red: cells with damaged cell
membrane).
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Figure 7.6. Reversible perrneabilization using 1:3 hypotonic buffer ratio and cell viability.
Comparison of bright field, fluorescence and viability representative images of H9c2 cells
treated with 1: 1 hypotonic buffer ratio for uptake of QDs for (A-C) 2 minutes, (D-F) 5
minutes and (G-I) 10 minutes respectively at 4°C. Bright field and fluorescence images are
obtained with 60 x magnification and cell viability images are obtained with lO x
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magnification. Cell viability fluorescence images (C, F and I) show fluorescence overlay
of ca1cein AM (green: live cells) and ethidium homodimer-l (red: cells with damaged cell
membrane) .
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Figure 7.7 LivelDead cell viability assay following hypotonic buffer treatment showing
live cells stained with calcein AM (green: live cells) and dead cells stained with ethidium
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homodimer-1 (red: cells with damaged cell membrane). Cells are treated with different
hypotonic buffer ratios (1:1, 3:2, 1:3) for different incubation times (2, 5 and 10 minutes)
at 4°C respectively .
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Figure 7.8 Quantitative analysis of internalized QDs with different hypotonic buffer ratios.
Histograms represent mean fluorescence intensity of cells (arbitrary units) for 1:1 ratio
(12.24, 17.62, 20.31), 3:2 ratio (10.65, 18.37, 18.96) and 1:3 ratio (11.64, 15.68, 17.41) for
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2 minutes (blue), 5 minutes (green) and 10 minutes (red) respectively. The mean
fluorescent intensity of cells without QDs used as negative control (gray) is 4.68.

Quantitative analysis of the percentage of live/dead cells is performed by counting
the number of live and dead cells from the cell viability images for a sample size of 5
(Figure 7.7). The QDs internalized are analyzed quantitatively using flow cytometry
analysis. The popUlation histograms representing the fluorescence intensity of the cells
internalized with QDs for different hypotonic buffer ratios (1: 1, 3 :2, 1:3) for 2 minutes, 5
minutes and 10 minutes are shown in Figure 7.8. The G mean which represents the mean
fluorescence intensity from the cells population for all the three different hypotonic buffer
conditions is 1:1 (12.24, 17.62,20.31),3:2 (10.65,18.37,18.96) and 1:3 (11.64, 15.68,
17.41) for 2 minutes, 5 minutes and 10 minutes at 4°C respectively. Cells without QDs
(negative control) have a mean fluorescence intensity of 4.68.
7.1.3 Reversible permeabilization using Saponin

This section deals with the results obtained from the reversible permeabilization
experiments for the intracellular delivery of QDs using Saponin. H9c2 cells are treated
with low concentrations of Saponin in the presence of hypotonic buffer conditions. The
cells are cultured for 24 hours prior to the permeabilization experiments. The 3:2
hypotonic ratio is chosen for all the Saponin experiments based on the distribution of QDs
inside the cells (Figure 7.5E) and the mean fluorescence intensity compared to the other
ratios. Cells are treated with QDs

(~1 OnM)

mixed in three different concentrations of

Saponin: 25Ilg/ml, 50llg/ml and 751lg/ml and are exposed for 2 minutes, 5 minutes and 10
minutes at 4°C in 3:2 hypotonic buffer ratio conditions. Live cell confocal microscopy is
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performed to evaluate the use of Saponin in conjunction with hypotonic exposure for the
internalization and intracellular distribution of QDs. Confocal phase contrast and
fluorescence images of cells with the internalized QDs when treated with 251lg/ml (Figure
7.9),50 Ilg/ml (Figure 7.10) and 75 Ilg/ml (Figure 7.11) in 3:2 hypotonic buffer conditions
for 2 minutes (A, B), 5 minutes (D, E) and 10 minutes (G, H) respectively are shown. The
results confirm that the QDs are well distributed within the cellular cytoplasm for all three
conditions and show higher homogenous distribution in the cytoplasm than with hypotonic
exposure alone. Particularly, the 50llg/ml concentration where cells are treated for 5
minutes (Figure 7.10 D, E) shows high QD internalization and uniform distribution of
QDs within the cytoplasm in comparison to the other conditions.
Representative cell viability fluorescence images shown in the panels C, F and I
(Figures 7.9, 7.10 and 7.11) show fluorescence overlay of calcein AM (green: live cells)
and ethidium homodimer-l (red: cells with damaged cell membrane) from the cells treated
with different hypotonic (3:2) Saponin concentrations (25Ilg/ml, 50llg/ml and 75Ilg/ml)
for different incubation times (2 minutes, 5 minutes and 10 minutes) at 4°C respectively.
As shown in the representative cell viability images, large number of live cells and
minimal or low number of dead cells is observed from high green and minimal red
fluorescence signal as a consequence of exposure to the different hypotonic Saponin
concentrations. However, higher Saponin concentrations or longer incubation times
resulted in some cell death. Quantitative analysis of the percentage of live/dead cells is
performed by counting the number of live and dead cells from the cell viability images for
a sample size of 5 (Figure 7.12). The QDs internalized are analyzed quantitatively using
flow cytometry analysis. The population histograms representing the fluorescence
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intensity of the cells internalized with QDs for different Saponin concentrations
50~g/ml

and

75~g/m1)

(25~g/m1,

for 2 minutes, 5 minutes and 10 minutes are shown in Figure 7.13.
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Figure 7.9 Reversible permeabilization usmg 25

~g/ml

Saponin and cell viability.

Comparison of bright field, fluorescence and viability representative images of H9C2 cells
treated with

25~g/ml

of Saponin for (A-C) 2 minutes, (D-F) 5 minutes and (G-I) 10

minutes respectively. Bright field and fluorescence images are obtained with 60 x
magnification and cell viability images were obtained with lOx magnification. Cell
viability fluorescence images (C, F and I) show fluorescence overlay of calcium AM
(green: live cells) and ethidium homodimer-1 (red: cells with damaged cell membrane).
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Figure 7.10 Reversible permeabilization using 50 Ilg/ml Saponin and cell viability.
Comparison of bright field, fluorescence and viability representative images of H9C2
cells treated with 251lg/ml of Saponin for (A-C) 2 minutes, (D-F) 5 minutes and (G-I) 10
minutes respectively. Bright field and fluorescence images are obtained with 60x
magnification and cell viability images were obtained with lOx magnification. Cell
viability fluorescence images (C, F and I) show fluorescence overlay of calcein AM
(green: live cells) and ethidium homodimer-l (red: cells with damaged cell membrane).
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Figure 7.11 Reversible permeabilization using 75

~g/ml

Saponin and cell viability.

Comparison of bright field, fluorescence and viability representative images of H9C2
cells treated with

25~g/ml

of Saponin for (A-C) 2 minutes, (D-F) 5 minutes and (G-I) 10

minutes respectively. Bright field and fluorescence images are obtained with 60 x
magnification and cell viability images were obtained with lO x magnification. Cell
viability fluorescence images (C, F and I) show fluorescence overlay of calcein AM
(green: live cells) and ethidiurn homodimer-l (red: cells with damaged cell membrane).
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Figure 7.12 LivelDead cell viability assay following Saponin treatment showing live cells
stained with calcein AM (green: live cells) and dead cells stained with ethidium
homodimer-l (red: cells with damaged cell membrane). Cells are treated with different
hypotonic (3:2) Saponin concentrations (251lg/ml, 50Ilg/ml and 751lg/ml) for different
incubation times (2, 5 and 10 minutes) at 4°C respectively.
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Figure 7.13 Quantitative analysis of internalized QDs with different Saponin
concentrations. Histograms represent mean fluorescence intensity for 251-lglml (9.59,
13.85, 11.99), 50l-lglml (10.21 , 16.43, 19.38) and 751-lglml (13.32, 16.97, 14.03) for 2
minutes (blue), 5 minutes (green) and 10 minutes (red) respectively. The mean fluorescent
intensity of cells without QDs used as negative control (gray) is 4.68.
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The G mean representing mean fluorescence intensity from the cells population
for all the three different hypotonic Saponin conditions are
50~g!ml

(10.21 , 16.43, 19.38) and

75~g/ml

25~g!ml

(9.59, 13 .85, 11.99),

(13 .32, 16.97, 14.03) for 2 min, 5 min and 10

min at 4°C respectively. Cells without QDs are used as negative control and have a mean
fluorescence intensity of 4.68
7.1.4 Reversible permeabilization using Saponin without hypotonic conditions

The significance of hypotonic buffer conditions for the effective reversible
permeabilization is evaluated by treating the H9c2 cells with Saponin in the absence of
hypotonic buffer. The concentration of Saponin chosen for this study is 125 ~g!ml. Though
this concentration is higher than the concentrations used with hypotonic buffer conditions
(25-75

~g!ml) ,

it is chosen due to the reason that lower concentrations of Saponin resulted

in poor intracellular uptake of QDs. In other words,

125~g!ml

represents the lowest

Saponin concentration where there is appreciable intracellular delivery of QDs. Even
though,

125~g!ml

of Saponin results in the intracellular delivery of QDs, poor cell

viability is observed (Figure 7.14). It is observed from confocal microscopy images
(Figure 7.14.A) that the cell membranes are damaged due to the Saponin treatment.
To further confirm the importance of hypotonic buffer conditions, cells are
evaluated for their viability using live/dead assay by treating cells with

125~g!ml

of

Saponin without hypotonic buffer. The controls used in this study are cells alone without
Saponin (0

~g!ml )

as negative control and cells with Saponin (1 mg/ml) as positive control.
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Figure 7.14 Reversible permeabilization usmg Saponin without hypotonic buffer
conditions. (A) phase contrast, (B) fluorescence images of cells treated QDs mixed in
125~g/ml

of Saponin without hypotonic buffer.

Representative phase contrast and fluorescence overlay microscopy images from
the live/dead assay for cells treated at different concentrations of Saponin, 0
(Figure7.15.A, B) 125

~g/ml

~g/ml

(Figure 7.15.C, D), 1 mg/ml (Figure 7.15.E, F) are shown. It

is observed from the live/dead bright field images for 125

~g/ml

and 1 mg/ml Saponin

concentrations that the cell membranes are irreversibly damaged. The fluorescence images
for these concentrations show that there is significant number of dead cells and minimal or
no live cells as evident from the bright red (dead cells) and very low green (live cells)
fluorescence. Quantitative analysis of the percentage of live/dead cells is performed by
counting the number of live (green) and dead (red) cells from the cell viability images for
a sample size of 5 (Figure 7.16). It is clearly evident that the 125

137

~g/ml

Saponin

concentration results in extensive cell death (> 98%) which is very similar to that of the
positive control, 1mg/ml.
7.2 DISCUSSION

The efficient intracellular delivery of QDs is potentially very attractive m
applications involving sub-cellular imaging as well as biomolecular transport to
manipulate cell signaling mechanisms. Even though, several methods exist for the QDs
intracellular delivery, most of them involve delivery of QDs as aggregates and not
monodisperse. The only technique currently available which successfully demonstrates
highly dispersed delivery of QDs is microinjection. However, this technique is very
laborious and time consuming as the delivery is accomplished one cell at a time. Hence,
an efficient method for the intracellular delivery of QDs which are freely dispersed in the
cells without being trapped in the vesicles is needed. A novel method which overcomes
the problems associated with the current techniques was developed in this dissertation.
This technique combines the hypotonic exposure with low concentrations of a cell
permeabilization agents like Saponin to accomplish reversible permeabilization of cell
membranes for QDs delivery. Performing this protocol at 4°C inhibits thermal energy
dependent mechanisms like endocytosis. Therefore, it ensures that uptake of QDs is
primarily due to this reversible permeabilization technique.
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Figure 7.15 Perrneabilization using Saponin without hypotonic conditions. Comparison of
bright field and fluorescence overlay images of calcein AM (green: live cells) and
ethidiurn homodimer-l (red: cells with damaged cell membrane) co-stained H9c2 cells
treated with (A, B) OJlg/rnl Saponin, cells only (negative control), (C, D) 125Jlg/rnl
Saponin without hypotonic buffer, (E, F) 1 mg/rnl Saponin without hypotonic buffer
(positive control) respectively.
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Figure 7.16 Quantitative analysis of live/dead cell assay performed on cells treated with
Saponin without hypotonic buffer conditions. Comparison of percentage of live/dead cells
stained with of calcein AM (green: live cells) and ethidium homodimer-1 (red: cells with
damaged cell membrane) is shown for 0 Jlglml Saponin i.e., cells alone (negative control),
125Jlglml Saponin without hypotonic buffer and 1 mglml Saponin without hypotonic
buffer (positive control) respectively.

It is observed that hypotonic exposure alone is sufficient for reversible

permeabilization of live cells for the delivery of QDs as seen from the Figures 7.4, 7.5 and
7.6. Furthermore, the cells treated with different hypotonic buffer conditions are show
high viability. It is experimentally determined that a 5min exposure of QDs to 3:2 buffer
to DI water results in uniform distribution of the cell internalized QDs. Moreover,
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hypotonic exposure in combination with Saponin treatment results in more efficient and
highly dispersed delivery of QDs. The mean fluorescence intensities are a measure of the
number of QDs inside the cells while the fluorescence images compare the distribution of
QDs within the cells. It was experimentally determined that a 5 min exposure to QDs
suspended in 3:2 buffer to DI water ratio with 50 Ilg/ml Saponin produced the best
dispersion of the internalized QDs within the cytoplasm. Cell viability was verified from
the live/dead assay which shows that this reversible permeabilization technique maintains
high cell viability. The viability study was performed after 30-45 min to be consistent with
the amount of time between recovery and imaging the cells with internalized QDs. The
live/dead viability assay is performed without QDs loading. This was due to the fact that
ca1cein-AM which is used to label live cells has emission around 517 nm which interferes
with QDs fluorescence emission

(~

530nm). Moreover, it was observed that the cells with

internalized QDs continued to divide and proliferate even after several days without any
apparent loss of viability.
The significance of hypotonic buffer conditions is twofold. First, it creates an
osmotic pressure gradient that drives fluid into the cell. This fluid transport results in the
intracellular of delivery of QDs. Second, it ensures unidirectional transport directed into
the cells. The cells contain various biomolecules and other important intracellular contents
which can diffuse out of the cells either during the creation of openings. This efflux results
in cell death and loss of proper function. Further, this bidirectional transport is highly
critical when the cells are treated with Saponin as it creates holes in the membrane. Thus,
the hypotonic buffer environment maintains the osmotic pressure gradient which ensures
cell viability and no net loss of vital intracellular contents. It is also observed that during
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reversible permeabilization using hypotonic buffer, 10 mm exposure to hypotonic
conditions, did not significantly enhance the number of internalized QDs. This can be
explained from the fact that after 5min the extracellular and intracellular environments
equilibrate with each other. This results in reduction in the pressure gradient and fluid
transport into the cell and diffusion occurs both into and out of the cells. Therefore, the
10min exposure time does not significantly enhance the number of internalized QDs as
seen from the mean fluorescence intensities from the flow cytometry analysis.
To further investigate the significance of hypotonic buffer conditions, experiments were
performed with Saponin in the absence of a hypotonic environment. The low
concentrations of Saponin used in combination without hypotonic buffer (25-75

~g/ml)

did not result in a significant uptake of QDs by the cells. Only when the concentration of
Saponin is raised to125

~g/ml,

an appreciable number of QDs are seen to be internalized

by the cells. Extensive cell death is observed when the cells are treated with 125

~g/ml

of

Saponin for 5 min without hypotonic conditions from the live/dead assay. This could
possibly be due to the leakage of vital intracellular contents out of the cell in the absence
of an osmotic pressure gradient across the membrane. Thus, the hypotonic exposure is
necessary to maintain cell viability during reversible permeabilization using Saponin.
Thus this reversible permeabilization technique using low concentrations of
Saponin with hypotonic buffer conditions is a highly efficient method for delivery of QDs
free in the cellular cytoplasm. The viability of the cells is not compromised following the
Saponin or hypotonic treatments. Despite the fact that all the experiments in this study
were performed using adherent cells, this technique is highly applicable for cells in
suspension. As Saponin targets cholesterol rich membranes, the delivery of QDs is highly

142

selective towards cytoplasmic delivery than nuclear delivery as clearly evident from the
confocal fluorescence images. Moreover, the osmotic pressure gradient is across the cell
membrane. This technique of reversible permeabilization using hypotonic Saponin is
applicable in in vitro studies such as labeling of the different intracellular components and
tracking of proteins and other subcellular biomolecules. The delivery of QDs based on
hypotonic buffer conditions alone is applicable in in vivo studies such as labeling of blood
leukocytes by selective lysis of red blood cells. Thus, this reversible permeabilization of
live cells technique wide applications in the delivery of QDs into cells for applications
such as imaging and biomolecular delivery. Furthermore, this technique can potentially
be extended to delivery of various other nanomaterials and also biomolecules into live
cells.
7.3 QDS: NF-kB P65 ANTIBODY CONJUGATES

This section deals with the preliminary results obtained from study to demonstrate
QDs conjugated NF-kB p65 antibodies have the ability to image the intracellular location
ofNF-kB protein. QDs are conjugated to NF-kB p65 antibodies and gel electrophoresis is
performed (Ocean Nanotech LLC) to confirm the conjugation ofNF-kB p65 antibodies to
QDs. It is observed from the gel electrophoresis data that the unconjugated QDs migrate
faster than the antibody conjugated QDs (Figure 7.17). QDs with

~

600 nm emission are

conjugated with NF-kB p65 antibodies using protein-G attachment. Gel electrophoresis is
used to confirm the conjugation of QDs to protein-G and QDs: pG conjugates to NF-kB
p65 antibodies (Figure 7.18). The tailing observed is due to the different number of
antibodies attached to each QD.
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Figure 7.17 Gel electrophoresis data confirming the conjugation of QDs with NF-kB p65
antibodies. Tailing is due to the different number of antibodies attached to each QD.
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Figure 7.18 Gel electrophoresis data confirming the conjugation of QDs with protein G
and with NF-kB p65 antibodies.

7.3.1 Stimulation of cells for activation and nuclear translocation of NF-kB

In addition to gel electrophoresis, the most definitive method to confirm the
bioconjugation of QDs is by performing a functional assay by testing the avidity of
antibody to its functional protein. The results shown in this section for labeling ofNF-kB
protein is accomplished using QDs with emission

~

530 nm and

~600nm .

Cells are

stimulated for the activation and translocation of NF-kB protein from the cytoplasm to
the nucleus. Cells stimulation is performed using stimuli like LPS (2 hours), TNF-a (1
hour) and UV radiation (2 hours). Following stimulation, immunofluorescence staining of
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NF-kB protein is performed using QDs: NF-kB p65 conj ugates. Confocal fluorescence
imaging of the cells revealed strong QDs fluorescence emerging from the nucleus for the
UV (Figure 7.19B), TNF-a (Figure 7.19C) and LPS (Figure 7.19D) stimulated cells. This
indicates successful labeling of nuclear NF-kB protein using the QDs: NF-kB p65
conjugates. The cells with strong nuclear fluorescence in the represented field of view are
shown (arrows). The TNF-a stimulated cells are stained for NF-kB using NF-kB p65
antibodies conjugated to QDs with - 600 nm emission. In the case of un-stimulated cells
(negative control), there is minimal nuclear fluorescence and only cytoplasmic
fluorescence signal (Figure 7.19A). This is expected as the cells are not stimulated, there
is no nuclear translocation ofNF-kB protein.
7.4 SUMMARY
In summary, the results shown in this chapter demonstrate the novel technique to
efficiently delivery QDs well dispersed in live cells. This technique combines the use of
hypotonic environments and low concentrations of cell permeabilization agents like
Saponin. Enhanced and well dispersed delivery of QDs is achieved when Saponin was
used in combination with hypotonic conditions in comparison to hypotonic conditions
alone. The ability of QDs to label subcellular proteins like NF-kB using QDs: NF-kB
p65 conjugates is also demonstrated. The reversible permeabilization technique can
potentially be used to track the nuclear translocation of NF-kB in live cells which
provides vital information regarding the activity of the protein. The next chapter
discusses the conclusions and potential future directions based on this dissertation
research.
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Figure 7.19 Stimulation of cells for activation and nuclear translocation of NF-kB
protein. Immunofluorescence on cells stained for NF-kB protein using QDs: NF-kB p65
antibodies for (A) unstimulated cells, (B) UV radiation, (C) TNF-a and (D) LPS
stimulated cells respectively. The arrows (white) are used to identify cells with nuclear
fluorescence. The 1NF-a stimulated cells are stained with QDs with ~ 600 nm emission.
All the images are taken with a magnification of 60x.
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CHAPTER VIII- CONCLUSIONS AND FUTURE DIRECTIONS

8.1 CONCLUSIONS
This dissertation research involves the use of two different nanomaterials for the
delivery well as imaging of the biomolecules with subcellular resolution. The dissertation
is divided into two parts - chapters III -V as first part and c chapters V-VII as the second
part.
In the first part, the biocompatibility of SWCNTs is thoroughly evaluated by
studying their interactions with the leukocytes in the blood. Blood is chosen as the
appropriate model as it is a living tissue and is a major mediator of immune homeostasis.
Two different interactions are recreated in vitro. In the direct interaction, the presence of
SWCNTs in blood circulation is studied by evaluating the response of leukocytes to
SWCNTs. In the indirect interaction, the presentation of SWCNTs to the blood leukocytes
via antigen presenting cells (APCs) is studied. The different subpopulations of the blood
leukocytes are identified using their respective phenotype markers and are evaluated for
their activation using their respective activation markers. Flow cytometry is used to
analyze the different subpopulations for any activation relative to controls.
Results from this study conclusively indicate minimal leukocyte activation
following both the direct and the indirect interactions with SWCNTs. The delivery of ssDNA

into

cells

usmg

SWCNTs

is
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also

demonstrated.

These

results

provide new information regarding the biocompatibility of nanotubes and support the use
of CNTs based approaches for intracellular delivery of genes and biomolecules.
In the second part of this dissertation, a new technique is demonstrated that
addresses common problems with nanomaterial delivery into cells like confinement in
vesicles and delivery as aggregates. It combines the use of a hypotonic buffer

III

combination with low concentrations of a cell permeabilization agent, Saponin to
accomplish reversible permeabilization of cells for delivery of QDs. This technique is
comparable to microinjection technique that has the highest success in intracellular QD
delivery with significantly higher throughput. The cell viability following this technique is
high and cells survive in culture for extended periods of time undergoing cell division.
This technique has great potential for delivery of QDs for both imaging and biomolecular
delivery applications. The preliminary results showing the labeling of an important
intracellular protein (NF-kB) using QDs is demonstrated.
8.2 FUTURE DIRECTIONS

The thorough study performed to evaluate the biocompatibility of SWCNTs paves
way for their safe use in the delivery of therapeutics, cancer diagnostics and tissue
engineering applications. The SWCNTs can be further functionalized with other relevant
biomolecules like nucleic acids, proteins or peptides for clinical applications. The
reversible permeabilization technique is easily applicable in the endocytosis free delivery
of not only QDs but also other nanomaterials. The technique accomplishes delivery of
nanomaterials in live cells and therefore has the potential to study intracellular processes
in real time. The nanomaterials based approaches described can be easily integrated into
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state of the art technologies utilizing microfluidic platforms for more efficient drug
delivery and disease diagnosis.
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